INST Instructure Holdings Inc

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14C INFORMATION

Information Statement Pursuant to Section 14(c) of the

Securities Exchange Act of 1934

Check the appropriate box:

Instructure Holdings, Inc.

(Name of Registrant as Specified In Its Charter)

Payment of Filing Fee (Check all boxes that apply):

PRELIMINARY INFORMATION STATEMENT SUBJECT TO COMPLETION

Instructure Holdings, Inc.

6330 South 3000 East, Suite 700

Salt Lake City, Utah 84121

NOTICE OF WRITTEN CONSENT AND APPRAISAL RIGHTS

AND INFORMATION STATEMENT

WE ARE NOT ASKING YOU FOR A PROXY AND

YOU ARE REQUESTED NOT TO SEND US A PROXY.

To our Stockholders:

This notice of written consent and appraisal rights and information statement is being furnished to the holders of common stock, par value $0.01 per share (the “Company Common Stock”), of Instructure Holdings, Inc., a Delaware corporation (“Instructure”), in connection with the Agreement and Plan of Merger, dated as of July 25, 2024 (the “Merger Agreement”), by and among Instructure, Icon Parent Inc., a Delaware corporation (“Parent”), and Icon Acquisition Sub Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”). A summary of the Merger Agreement is provided in the accompanying information statement and a copy of the Merger Agreement is attached as Annex A to the accompanying information statement, and each are incorporated by reference into this notice. Parent and Merger Sub are each affiliates of investment funds managed by Kohlberg Kravis Roberts & Co. L.P., a Delaware limited partnership (“KKR”), a leading global investment firm. Pursuant to the Merger Agreement, Merger Sub will be merged with and into Instructure, with Instructure surviving as a wholly owned subsidiary of Parent (the “Merger”). Upon consummation of the Merger, on the terms and subject to the conditions set forth in the Merger Agreement, each share of Company Common Stock issued and outstanding as of immediately prior to the effective time of the Merger (the “Effective Time”) will be automatically cancelled, extinguished and converted into the right to receive cash in an amount equal to $23.60 per share, without interest thereon and subject to applicable withholding taxes. However, the Merger consideration will not be paid in respect of (i) any shares of Company Common Stock held by Instructure as treasury stock, held by any subsidiary of Instructure or owned by Parent or any of its subsidiaries (including Merger Sub), in each case as of immediately prior to the Effective Time, which shares will automatically be cancelled and extinguished without any conversion thereof or consideration paid therefor and (ii) those shares of Company Common Stock held by any person who is entitled to demand, and who has properly demanded, appraisal of such shares of Company Common Stock under Delaware law and not withdrawn his, her or its demand for appraisal or has not lost or waived such rights.

The board of directors of Instructure has unanimously (i) determined that it is fair to, and in the best interests of, Instructure and its stockholders, and declared it advisable, to enter into the Merger Agreement providing for the Merger, with Instructure being the surviving corporation in the Merger, in accordance with the General Corporation Law of the State of Delaware (the “DGCL”), upon the terms and subject to the conditions set forth in the Merger Agreement; (ii) approved and declared advisable the Merger Agreement, the execution and delivery of the Merger Agreement by Instructure, the performance by Instructure of its covenants and other obligations under the Merger Agreement, and the consummation of the Merger and the other transactions contemplated by the Merger Agreement upon the terms and subject to the conditions set forth in the Merger Agreement; and (iii) resolved to recommend that the holders of Company Common Stock adopt the Merger Agreement in accordance with the DGCL.

The adoption of the Merger Agreement by Instructure’s stockholders required the affirmative vote or consent by holders of a majority of the voting power of the outstanding shares of Company Common Stock entitled to vote thereon. On July 25, 2024, following the execution of the Merger Agreement, Thoma Bravo Fund XIII, L.P., Thoma Bravo Fund XIII-A, L.P. and Thoma Bravo Executive Fund XIII, L.P. (collectively, the “Principal Stockholders”), which together on July 25, 2024 held of record and beneficially owned 122,065,804 shares of Company Common Stock representing approximately 83.3% of the aggregate voting power of the then issued and outstanding shares of Company Common Stock, delivered a written consent approving and adopting in all respects the Merger Agreement and the transactions contemplated by the Merger Agreement, including the Merger (the “Written Consent”). As a result, no further action by any stockholder of Instructure is required under applicable law or the Merger Agreement (or otherwise) to adopt the Merger Agreement, and Instructure will not be soliciting your vote for or consent to the adoption of the Merger Agreement and the approval of the transactions contemplated by the Merger Agreement and will not call a stockholders’ meeting for purposes of voting on the adoption of the Merger Agreement and the approval of the transactions contemplated by the Merger Agreement. This notice and the accompanying information statement shall constitute notice to you from Instructure of the Written Consent contemplated by Section 228(e) of the DGCL.

Under Section 262 of the DGCL, if the Merger is completed, subject to compliance with the requirements of Section 262 of the DGCL, holders of shares of Company Common Stock, other than the Principal Stockholders, will have the right to seek an appraisal for, and be paid the “fair value” in cash of, their shares of Company Common Stock (as determined by the Delaware Court of Chancery), together with interest, if any, on the amount determined to be fair value, instead of receiving the Merger consideration pursuant to the Merger Agreement. To exercise your appraisal rights, you must submit a written demand for an appraisal to Instructure no later than twenty (20) days after the mailing of this information statement, which mailing date is on    , and comply precisely with all of the procedures set forth in Section 262 of the DGCL, which are summarized in the accompanying information statement. A copy of Section 262, which details the applicable Delaware appraisal statute, may be accessed without subscription or cost at the following publicly available website: https://delcode.delaware.gov/title8/c001/sc09/index.html#262. This notice and the accompanying information statement shall constitute notice to you from Instructure of the availability of appraisal rights under Section 262 of the DGCL in connection with the Merger.

We urge you to read the entire information statement carefully. If the Merger is completed, you will receive instructions regarding payment for your shares of Company Common Stock.

BY ORDER OF THE BOARD OF DIRECTORS,

Neither the U.S. Securities and Exchange Commission nor any state securities regulatory agency has approved or disapproved the Merger, passed upon the merits or fairness of the Merger or passed upon the adequacy or accuracy of the disclosures in this notice or the accompanying information statement. Any representation to the contrary is a criminal offense.

This information statement is dated    and is first being mailed to stockholders on    .

ii

TABLE OF CONTENTS

i

ii

2

3

4

5

6

7

8

9

10

11

12

QUESTIONS AND ANSWERS ABOUT THE MERGER

The following questions and answers are intended to briefly address commonly asked questions as they pertain to the Merger Agreement and the Merger. These questions and answers may not address all questions that may be important to you as an Instructure stockholder. Please refer to the “Summary” beginning on page 1 and the more detailed information contained elsewhere in this information statement, the annexes to this information statement and the documents referred to or incorporated by reference in this information statement, each of which you should read carefully. You may obtain additional information, which is incorporated by reference in this information statement, without charge by following the instructions in “Where You Can Find More Information” beginning on page 89.

At the Effective Time, each Unvested Company RSU will automatically be cancelled and replaced with a right to receive an amount in cash (without interest and subject to applicable withholding taxes), equal to the Cash Replacement Company RSU Amounts, which Cash Replacement Company RSU Amounts will, subject to the holder’s continued service with Parent or its subsidiaries (including, following the Effective Time, the surviving corporation or its subsidiaries) through the applicable vesting dates, vest and be payable at the same time as the Unvested Company RSUs for which the Cash Replacement Company RSU Amounts were exchanged would have vested and been payable pursuant to their terms (including with respect to any terms providing for acceleration of vesting pursuant to any employee plan), and will otherwise have the same terms and conditions as applied to the Unvested Company RSUs for which they were exchanged, except for terms rendered inoperative by reason of the Transactions or for such other administrative or ministerial changes as in the reasonable and good faith determination of Parent are appropriate to conform the administration of the Cash Replacement Company RSU Amounts.

13

At the Effective Time, each Vested Company PSU will automatically be cancelled and converted into the right to receive an amount in cash (without interest and subject to applicable withholding taxes) equal to the product of (i) the Per Share Price and (ii) the total number of shares of Company Common Stock subject to such Vested Company PSU as of immediately prior to the Effective Time.

At the Effective Time, each Unvested Company PSU will automatically be cancelled and converted into the right to receive an amount in cash (without interest and subject to applicable withholding taxes) equal to the Cash Replacement Company PSU Amounts, which Cash Replacement Company PSU Amounts will, subject to the holder’s continued service with Parent or its subsidiaries (including, following the Effective Time, the surviving corporation or its subsidiaries) through the applicable vesting dates, vest and be payable at the same time as the Unvested Company PSUs for which the Cash Replacement Company PSU Amounts were exchanged would have vested and been payable pursuant to their terms (including with respect to any terms providing for acceleration of vesting pursuant to any employee plan); provided that, to the extent any Unvested Company PSU remains outstanding and subject to such performance vesting conditions as of immediately prior to the Effective Time, the performance metrics of such Unvested Company PSU will be deemed achieved at actual levels of performance effective as of the Effective Time, to be measured with pro-ration based on the portion of the performance period that has elapsed prior to the Effective Time, in good faith by the compensation committee of the Board. All Cash Replacement Company PSU Amounts will have the same terms and conditions (including with respect to time-based vesting) as applied to the Unvested Company PSU for which they were exchanged, except for terms rendered inoperative by reason of the Transactions or for such other administrative or ministerial changes as in the reasonable and good faith determination of Parent are appropriate to conform the administration of the Cash Replacement Company PSU Amounts.

As promptly as reasonably practicable after the closing date, but no later than five business days after the closing date, the holders of Vested Company RSUs and Vested Company PSUs will be paid by Instructure or the surviving corporation, through its payroll system or payroll provider, all amounts required to be paid to such holders in respect of Vested Company RSUs and Vested Company PSUs that are cancelled and converted into a cash payment, less any applicable withholding taxes.

14

15

16

A Non-United States Holder will generally not be subject to United States federal income tax on any gain resulting from the exchange of Company Common Stock pursuant to the Merger, unless such holder has certain connections to the United States. However, the Merger could be a taxable transaction to such holder under non-United States tax laws applicable to such holder.

Holders of Company Common Stock should read the section entitled “The Merger—Material United States Federal Income Tax Consequences of the Merger” beginning on page 50 for a more detailed description of the United States federal income tax consequences of the Merger. Tax matters can be complicated, and the tax consequences of the Merger to you will depend on your particular situation. Holders of Company Common Stock are urged to consult their own tax advisors about the United States federal, state, local and non-United States tax consequences of the Merger.

17

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This information statement, and the documents to which we refer you in this information statement, contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act, including, without limitation, statements regarding forecasts and projections as described in “The Merger—Certain Company Financial Forecasts” beginning on page 41, which are subject to the “safe harbor” created by those sections. Forward-looking statements are based on our management’s beliefs and assumptions and on information currently available to our management. All statements other than statements of historical facts included in this information statement are forward-looking statements, including those relating to future events or our future financial performance and financial guidance. In some cases, you can identify forward-looking statements by terminology such as “may,” “might,” “will,” “should,” “expect,” “plan,” “anticipate,” “project,” “believe,” “estimate,” “predict,” “potential,” “intend” or “continue,” the negative of terms like these or other comparable terminology, and other words or terms of similar meaning in connection with any discussion of future operating or financial performance. For example, all statements we make relating to our current expectations relating to the Merger and the transactions contemplated by the Merger Agreement, estimated and projected costs, expenditures, cash flows, growth rates and financial results, our plans and objectives for future operations, growth initiatives, or strategies, industry, market and macroeconomic expectations, or future business and product capabilities are forward-looking statements. These statements are only predictions. You should not place undue reliance on our forward-looking statements. These statements are not guarantees of future performance and are subject to future events, risks and uncertainties, many of which are beyond our control, or currently unknown to us. Our assumptions may turn out to be inaccurate and actual events or results may differ materially from our expectation or projections. All forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those that we expected, including:

18

We derive many of our forward-looking statements from our operating budgets and forecasts, which are based on many detailed assumptions. While we believe that our assumptions are reasonable, we caution that it is very difficult to predict the impact of known factors, and it is impossible for us to anticipate all factors that could affect our actual results. All written and oral forward-looking statements attributable to us, or persons acting on our behalf, are expressly qualified in their entirety by this cautionary statement as well as other cautionary statements that are made from time to time in our other SEC filings and public communications. You should evaluate all forward-looking statements made in this information statement in the context of these risks and uncertainties.

We caution you that the important factors referenced above may not contain all of the factors that are important to you. In addition, we cannot assure you that we will realize the results or developments we expect or anticipate or, even if substantially realized, that they will result in the consequences or affect us or our operations in the way we expect. The forward-looking statements included in this information statement are made only as of the date hereof. We undertake no obligation to update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

19

THE PARTIES TO THE MERGER AGREEMENT

Instructure

Instructure Holdings, Inc.

6330 South 3000 East, Suite 700

Salt Lake City, Utah 84121

Phone: (800) 203-6755

Instructure is a provider of a learning platform that delivers the elements that leaders, teachers, and learners need – a next-generation LMS, robust assessments for learning, actionable analytics, and engaging, dynamic course content. Instructure is the LMS market share leader in both Higher Education and paid K-12, and as of June 30, 2024, it had over 8,000 global customers, representing Higher Education institutions and K-12 districts and schools in more than 100 countries. Instructure’s principal executive offices are located at 6330 South 3000 East, Suite 700 Salt Lake City, UT 84121 and its telephone number is (800) 203-6755. Instructure’s website is www.instructure.com. Additional information about Instructure is included in documents incorporated by reference into this information statement and our filings with the SEC, copies of which may be obtained without charge by following the instructions in “Where You Can Find More Information” beginning on page 89.

The Company Common Stock is listed with, and trades on, the NYSE under the symbol “INST.”

Parent

Icon Parent Inc.

c/o Kohlberg Kravis Roberts & Co. L.P.

30 Hudson Yards

New York, NY 10001

Phone: (877) 610-4910

Parent is a Delaware corporation that was formed solely for the purpose of entering into the Merger Agreement, consummating the Merger and engaging in the transactions contemplated by the Merger Agreement, and has not engaged in any business activities other than in connection with the transactions contemplated by the Merger Agreement and arranging of the equity financing and debt financing in connection with the Merger. Parent is an affiliate of investment funds managed by KKR. After the consummation of the Merger, Instructure will be a wholly owned subsidiary of Parent. Parent’s principal executive offices are located at c/o Kohlberg Kravis Roberts & Co. L.P., 30 Hudson Yards, New York, NY 10001 and its telephone number is (877) 610-4910.

Merger Sub

Icon Acquisition Sub Inc.

c/o Kohlberg Kravis Roberts & Co. L.P.

30 Hudson Yards

New York, NY 10001

Phone: (877) 610-4910

Merger Sub is a Delaware corporation that was formed by Parent solely for the purpose of entering into the Merger Agreement, consummating the Merger and engaging in the transactions contemplated by the Merger Agreement. Merger Sub is a wholly owned subsidiary of Parent and has not carried on any business activity other than in connection with the transactions contemplated by the Merger Agreement. Upon consummation of the Merger, Merger Sub will cease to exist. Merger Sub’s principal executive offices are located at c/o Kohlberg Kravis Roberts & Co. L.P., 30 Hudson Yards, New York, NY 10001 and its telephone number is (877) 610-4910.

20

THE MERGER

Background of the Merger

The following chronology summarizes the key meetings and events that led to the signing of the Merger Agreement. The following chronology does not purport to catalogue every conversation among the Board, the Transaction Committee or the representatives of the Company and other parties.

The Board and the Company’s senior management periodically review the Company’s long-term strategy and objectives in light of market and industry conditions. These reviews have included, among other things, consideration of organic growth initiatives, acquisitions, divestitures, and potential business combination transactions, as well as other strategic opportunities, in each case with a view towards enhancing stockholder value.

On February 3, 2023, the Chief Executive Officer of a strategic party (“Party A”) and Steve Daly, the Chief Executive Officer of the Company, met in person at an industry conference they were both attending. After the conference, Mr. Daly and the Chief Executive Officer of Party A had an introductory discussion regarding the Company’s business. No specific transaction was discussed and no proposal was made with respect to any acquisition or other transaction between Party A and the Company during this conversation.

On February 9, 2023, the Chief Executive Officer of Party A contacted Holden Spaht, who serves as a director on the Board and is a managing partner of the Company’s controlling stockholder, Thoma Bravo, on an unsolicited basis to express interest in discussing a potential strategic transaction involving the Company. The Chief Executive Officer of Party A and Mr. Spaht had a preexisting business relationship unrelated to the Company. No specific transaction was discussed and no proposal was made with respect to any acquisition or other transaction between Party A and the Company during this conversation. Mr. Spaht informed the Chief Executive Officer of Party A that he would inform Mr. Daly and the rest of the Board of the inquiry.

On February 12, 2023, the Board convened a meeting attended by the Company’s outside legal advisor, Kirkland & Ellis LLP (“K&E”). Mr. Daly and Mr. Spaht informed the Board of the February 3rd and February 9th discussions with Party A, and Mr. Daly requested direction from the Board with respect to whether and to what extent he should engage in further discussions with Party A. In light of the inbound interest, K&E also reviewed with the Board its fiduciary duties under Delaware law and discussed process safeguards and considerations relevant to potential strategic transactions involving a Delaware corporation. K&E also provided the Board with guidance regarding the sharing of information with a third party, particularly information that could be considered material, non-public information. After discussion, the Board authorized Mr. Daly to continue discussions with Party A, subject to Party A’s execution of a confidentiality agreement.

On February 13, 2023, the Company entered into a confidentiality agreement with Party A. The confidentiality agreement included customary nondisclosure and nonuse provisions and a standstill provision that prohibited Party A (for an agreed-upon period) from (among other things) offering to acquire or acquiring the Company, and from taking certain other actions, including soliciting proxies, in each case without the prior consent of the Company. The confidentiality agreement permitted Party A to make acquisition proposals at any time after the Company enters into a definitive agreement with a third party providing for a change of control transaction of the Company.

On February 21, 2023, the Company’s management provided Party A with certain preliminary information concerning the Company, including an overview of the Company’s 2023 annual operating plan and responses to certain diligence requests made by Party A.

On March 10, 2023, Mr. Daly and Matt Kaminer, the Company’s Chief People and Legal Officer, met in person with representatives of Party A to discuss the Company’s strategic plan and the education technology industry generally. The participants in the discussion did not discuss any specific transaction, and no proposals with respect to a potential strategic transaction were made during this meeting.

21

On March 17, 2023, the Board convened a meeting attended by representatives of K&E and J.P. Morgan, the Company’s financial advisor, who had been invited to the meeting at the request of the Board due to, among other things, J.P. Morgan’s experience and its qualifications in connection with strategic acquisitions, as well as its longstanding relationship and familiarity with the Company and the industry in which the Company operates. During the meeting, Mr. Daly provided the Board with an update on Party A’s interest in continuing discussions regarding a potential strategic transaction. While the Board made no decision with respect to pursuing a transaction with Party A or any other similar transaction, the Board determined to form an ad-hoc transaction committee (the “Transaction Committee”) for convenience and efficiency in considering, evaluating and responding to any potential proposals from Party A or any other parties. Messrs. Daly and Spaht, as well as Brian Jaffee, who serves as a director on the Board and is a partner at Thoma Bravo, all of whom had significant experience with the Company and mergers and acquisition transactions, were appointed to the Transaction Committee. The Board authorized the Transaction Committee to assist management with respect to responding to any inquiries from Party A or any other parties and to provide timely Board input on issues as they arose; provided that any potential transaction involving the Company would need to be approved by the full Board. J.P. Morgan then presented to the Board regarding its qualifications as a financial advisor and subsequently left the meeting. The Board thereafter approved the Company’s engagement of J.P. Morgan as a financial advisor with respect to a potential transaction, subject to the receipt of J.P. Morgan’s customary conflict disclosures and the satisfactory review thereof by the Board (as described below).

On March 27, 2023, a representative of Party A informed a member of the Transaction Committee that it was no longer interested in pursuing a strategic transaction because Party A believed the Company did not meet its investment criteria at that time. Later, on March 27, 2023, the Board disbanded the Transaction Committee in light of the response from Party A.

On February 7, 2024, the Chief Executive Officer of Party A called Mr. Spaht to inform him that Party A had continued to track the Company’s performance since the prior year’s discussions and asked for an update on the Company’s business. Mr. Spaht did not provide an update on the business at this time, but suggested a more in-depth discussion at a later date.

On March 5, 2024, Mr. Spaht and Jamie Hutter, who serves as a director on the Board and is a Principal of Thoma Bravo, met in person with representatives of Party A to provide Party A with an update on the Company’s business. At the meeting, Mr. Spaht and Mr. Hutter shared confidential information about the Company with such representatives of Party A. The participants in the discussion did not discuss any specific transaction, and no proposals with respect to a potential strategic transaction were made during this meeting. The Company’s confidentiality agreement with Party A entered into on February 13, 2023 was still in effect at this time and at all times during any renewed discussions with Party A.

On March 17, 2024, at the request of a member of the Board in light of the renewed interest from Party A, a representative of J.P. Morgan compiled and provided to members of the Board an initial list of additional third parties that might be interested in a potential transaction with the Company. The list was compiled based on such third parties’ expertise and industry knowledge, considering various factors that, among other things, reflected such third parties’ knowledge of (and historical interest in) the Company and the broader industry sector in which it operates, their historical acquisition activity profile, their perceived approach to valuation and risk tolerance and such third parties’ perceived ability to finance an acquisition of the Company.

On March 19, 2024, representatives of J.P. Morgan held a videoconference with Lloyd “Buzz” Waterhouse, Charles Goodman, Mr. Jaffee and Mr. Spaht, as representatives of the Board, to discuss the proposed list. Following the call, the list was revised based on feedback from the videoconference and then provided to the full Board. Following final review and approval by the Board, later that day, Mr. Waterhouse authorized J.P. Morgan to initiate outreach on behalf of the Board to the agreed upon parties (which consisted of nine private equity firms (including KKR) and two strategic buyers), with the direction that material non-public information concerning the Company would not be provided to any party until execution of a customary confidentiality agreement.

22

Beginning on March 19, 2024, as authorized by the Board, J.P. Morgan initiated outreach to those eleven parties approved by the Board on March 19, 2024. Nine (which consisted of eight private equity firms, including KKR, and one strategic buyer) of such eleven parties expressed interest in entering into confidentiality agreements and attending management presentations and the other two parties included in the initial outreach beginning on March 19, 2024 declined to execute a confidentiality agreement and did not participate in a management presentation. Between March 25, 2024 and June 3, 2024, the Company entered into confidentiality agreements with such nine potential interested parties, including with KKR on April 26, 2024. Each confidentiality agreement included customary nondisclosure and nonuse provisions and a standstill provision that prohibited the party (for an agreed-upon period) from (among other things) offering to acquire or acquiring the Company, and from taking certain other actions, including soliciting proxies, in each case without the prior consent of the Company. Each confidentiality agreement permitted the party to make acquisition proposals at any time after the Company enters into a definitive agreement with a third party providing for a change of control transaction of the Company. Each party was provided access to a management presentation and other financial information upon entry into a confidentiality agreement.

Between March 25, 2024 and June 14, 2024, Mr. Daly and other members of the Company’s senior management gave management presentations to twelve interested parties total (including the nine parties in the initial outreach) who had signed confidentiality agreements, including KKR, private equity firms we refer to as Party B, Party C, Party D, Party E, Party F, Party G, Party I and a potential strategic acquiror we refer to as Party H. As described below, Party G, Party I and Party H were not included in the initial outreach. Representatives of J.P. Morgan were in attendance at each of these meetings. The participants in these sessions did not discuss any specific transaction, and no proposals with respect to a potential strategic transaction were made during these meetings.

On April 30, 2024, the Board convened a regularly scheduled meeting during which the Company’s management provided an update on the various meetings that had occurred, or were still scheduled to occur in the future, with potentially interested parties. While the Board made no decision with respect to pursuing a transaction, the Board determined to re-establish the Transaction Committee comprised of the same members and having the same authorizations and purpose as was established the prior year, which committee was established for convenience and efficiency in considering, evaluating and responding to any potential proposals from any parties, as well as to respond to inquiries from parties and to provide timely input on issues as they arose.

On May 7, 2024, J.P. Morgan informed members of the Transaction Committee of an unsolicited inbound inquiry from a private equity firm that was not included in the initial outreach (Party G). The Transaction Committee approved J.P. Morgan engaging with Party G and the Company’s entry into a confidentiality agreement with Party G substantially similar to the other confidentiality agreements used with other interested parties.

Between May 10, 2024 and May 14, 2024, Mr. Daly, other members of the Company’s senior management and representatives of J.P. Morgan held separate financial diligence sessions with six of the private equity firms that had previously participated in management presentations and requested such sessions, which included KKR, Party B, Party C, Party D, Party E and Party F. The participants in the discussions did not discuss any specific transaction, and no proposals with respect to a potential strategic transaction were made during these meetings.

On May 15, 2024, the date verbally communicated by representatives of J.P. Morgan to bidders as the deadline for submitting indications of interest with respect to a potential transaction with the Company, a representative of Party E and a representative of KKR submitted non-binding indications of interest to J.P. Morgan to acquire all of the outstanding shares of Company Common Stock for a proposed price between $23.00 and $26.00 per share and $24.50 per share, respectively. Later that day, representatives of J.P. Morgan communicated such indications of interest verbally to members of the Transaction Committee.

On May 17, 2024, following the closing of trading on the NYSE, Thomson Reuters reported that Thoma Bravo was exploring a sale of the Company (the “Reuters Article”). The Reuters Article also stated that Thoma Bravo had engaged J.P. Morgan to gauge the interest of potential buyers, including other private equity firms.

23

On May 20, 2024, a representative of Party F submitted a non-binding indication of interest to J.P. Morgan to acquire all of the outstanding shares of Company Common Stock for a proposed price between $22.00 and $23.00 per share. Later that day, representatives of J.P. Morgan communicated such indication of interest verbally to members of the Transaction Committee.

On May 21, 2024, the Transaction Committee convened a meeting with J.P. Morgan in attendance. J.P. Morgan summarized the terms of the three indications of interest and the status of each party’s due diligence review of the Company and discussed with the Transaction Committee potential approaches to further gauge the parties’ interest in a strategic transaction involving the Company. The Transaction Committee discussed, among other things, the recent conversations with each party, the merits of the indications of interest from KKR, Party E and Party F, and related process considerations. The Transaction Committee also discussed with J.P. Morgan other alternatives, including the possibility of soliciting interest from other potential bidders. Following discussion, the Transaction Committee determined to recommend to the Board that, in light of discussions to date with KKR, Party E and Party F, who were perceived as the most likely potential acquirers of the Company because of their knowledge of the industry, level of diligence completed to that point and submission of an indication of interest by or promptly following the requested deadline, it was advisable and in the best interests of the Company’s stockholders to focus engagement with those three parties. The Transaction Committee determined not to expand outreach to any additional parties at that time because the Reuters Article had been published and any interested third parties would have the opportunity to make unsolicited inbound inquiries based on the reporting that Thoma Bravo was exploring a sale of the Company.

On May 22, 2024, a representative of J.P. Morgan informed KKR, Party E and Party F that the Company would continue to engage with them with respect to pursuing a potential acquisition of the Company.

On May 24, 2024, KKR requested permission from J.P. Morgan to contact certain co-investors with respect to providing equity financing to KKR in connection with its potential acquisition of the Company. Representatives of J.P. Morgan relayed this request to members of the Transaction Committee, but such permission was not granted at this time.

On May 26, 2024, the Transaction Committee approved the opening of the data room and granted access to KKR, Party E and Party F.

On May 29, 2024, the Transaction Committee provided an update to the Board via email on the outcome of the outreach initiated on March 19, 2024 to potential acquirors of the Company and a recommendation for next steps. The Transaction Committee recommended to the Board that, in light of the indications of interest, they move forward with further discussions with three parties—KKR, Party E and Party F—all of whom had already done substantial diligence on the Company, have experience in the broader education technology sector and have the financial resources to execute a transaction of this size. The Board instructed the Company’s management team and advisors to continue to engage with the three parties and provide them with additional diligence information about the Company. In addition, the Transaction Committee noted that Party H recently expressed interest in evaluating a potential transaction involving the Company. While Party H, a strategic acquiror, had not yet started any diligence work on the Company, the Board directed the Company’s management and advisors to engage with them to determine their interest in pursuing a potential transaction in light of Party H’s knowledge of the industry in which the Company operates and its financial resources, including providing diligence information after execution of a confidentiality agreement. Finally, the Transaction Committee recommended that parties be requested to complete their work and provide final bids by the end of June. On May 29, 2024, the Board received an unsolicited inbound inquiry from a private equity firm (Party I) that was not included in the initial outreach. The Transaction Committee approved J.P. Morgan engaging with Party I and the Company’s entry into a confidentiality agreement with Party I substantially similar to the other confidentiality agreements used with other interested parties participating in the process.

24

On May 29, 2024, the Company entered into a confidentiality agreement with Party H having substantially similar terms as those entered into with other parties participating in the process.

On May 29, 2024 and May 31, 2024, Mr. Daly and members of the Company’s senior management hosted a business diligence session with Party F. The participants in the session did not discuss any specific transaction, and no proposals with respect to a potential strategic transaction were made during this meeting.

On May 30, 2024, KKR again requested permission from J.P. Morgan to contact certain potential equity co-investors and representatives of J.P. Morgan relayed this request to members of the Transaction Committee. The Transaction Committee provided their approval to representatives of J.P. Morgan, and this permission was relayed to KKR later that day.

On May 31, 2024 and June 4, 2024, Mr. Daly and members of the Company’s senior management hosted business diligence sessions with KKR. The participants in the discussions did not discuss any specific transaction, and no proposals with respect to a potential strategic transaction were made during these meetings.

On June 5, 2024, the Company’s management prepared an initial draft of its five-year long-range projections, based upon projections and data used in preparation for the Company’s investor day on March 12, 2024 and previously reviewed and approved by the Board, which were provided in the data room and to J.P. Morgan for use in connection with its financial analyses and potential opinion.

Between June 6, 2024 and June 20, 2024, members of the Company’s senior management and representatives of J.P. Morgan participated in several due diligence sessions with KKR, Party E and Party F and their respective representatives.

On June 11, 2024, Party F contacted representatives of J.P. Morgan to notify them that Party F was no longer interested in pursuing the potential transaction because they would be unwilling to increase their proposed price above the range set forth in their previous indication of interest and believed such price would not be competitive with other parties. Later that day, representatives of J.P. Morgan communicated this verbally to members of the Transaction Committee.

On June 13, 2024, representatives of Party E contacted representatives of J.P. Morgan to discuss their previously submitted indication of interest and noted that they were still completing their diligence process, but that their bid would likely be lower than the range provided in such indication of interest. Later that day, representatives of J.P. Morgan communicated this verbally to members of the Transaction Committee.

On June 15, 2024, a member of the Transaction Committee, Mr. Jaffee, sent an email update to the Board indicating that two of the three private equity bidders (Party E and KKR) continue to spend considerable time and effort on diligence and the other private equity bidder (Party F) was no longer interested in pursuing the potential transaction. Mr. Jaffee noted that management had multiple meetings with each of the bidders, including financial, product and M&A focused meetings. Mr. Jaffee indicated the Transaction Committee would ask the remaining parties to submit updated indications of interest by the end of the following week. Mr. Jaffee’s email attached a summary of the key terms for a Merger Agreement that would be posted to the data room and an overview of the director’s fiduciary duties and process considerations prepared by K&E.

On June 17, 2024, the Company’s management updated the initial management projections prepared on June 5, 2024 to, among other things, account for a recent acquisition by the Company and the management projections were finalized (the “Management Forecasts” as discussed in further detail in the section of this information statement entitled “—Certain Company Financial Forecasts” beginning on page 41). The Board approved the Management Forecasts to be used by the Board to compare the standalone business of the Company to any proposals received from counterparties, and authorized the Company’s management to distribute the projections to potential counterparties and to J.P. Morgan for J.P. Morgan’s use in connection with its financial analyses and potential opinion.

25

On June 21, 2024, representatives of KKR verbally communicated to representatives of J.P. Morgan that while KKR was still interested in acquiring all of the outstanding shares of Company Common Stock, the per share price at which it would be willing to do so would likely be lower than KKR’s previously communicated price of $24.50 per share unless KKR was able to secure equity co-investors for a portion of the required equity financing who were willing to invest at that original price. Also on June 21, 2024, representatives of KKR also requested approval to contact lenders and additional equity co-investors regarding providing financing in connection with a potential acquisition of the Company. Representatives of J.P. Morgan relayed this request to members of the Transaction Committee, but such such permission was not granted at this time.

On June 24, 2024, a representative of KKR and representatives of J.P. Morgan held a teleconference where such representative of KKR reiterated that KKR remained interested in acquiring all of the outstanding shares of Company Common Stock at a price of $24.50 per share provided that it could secure co-investors to provide a portion of the equity financing at that price. Following this teleconference, KKR again requested approval to contact lenders and additional equity co-investors and representatives of J.P. Morgan relayed this request to members of the Transaction Committee. The Transaction Committee provided their approval to representatives of J.P. Morgan, and this permission was relayed to KKR later that day. Representatives of J.P. Morgan also provided an update to members of the Transaction Committee about its discussions with representatives of KKR.

On June 24, 2024, representatives of Thoma Bravo contacted a representative of Dragoneer Investment Group, LLC (“Dragoneer”) to gauge Dragoneer’s interest in providing equity financing for the potential acquisition of the Company because Dragoneer had met with the Company’s management in the past (prior to commencing this process) and Thoma Bravo was aware that representatives of Dragoneer had been tracking the Company’s growth. The representative of Dragoneer indicated that Dragoneer may be interested in pursuing a co-invest opportunity with a buyer of the Company.

On June 25, 2024, Mr. Jaffee and a representative of KKR held a teleconference to discuss the June 24, 2024 conversation between such representative of KKR and representatives of J.P. Morgan, the remaining open diligence items and the timing for the potential acquisition. The representative of KKR indicated that KKR would need a few weeks to obtain the equity financing necessary for the acquisition.

On June 25, 2024, a draft of the Merger Agreement that was prepared by K&E was posted in the Company’s data room for bidders. The draft Merger Agreement included, among other terms and conditions, (i) private equity-style financing, which included equity and debt commitment letters as well as a limited guarantee from an investment fund affiliated with the bidder, (ii) a “go-shop” provision that would enable the Company to solicit alternative bids for 40 days after signing of the Merger Agreement, (iii) that the Principal Stockholders would not deliver a written consent to approve the merger until after the termination of the “go-shop” period, (iv) a termination fee payable by the Company equal to 1.0% of the Company’s fully diluted equity value based on the per share price if the Merger Agreement was terminated under certain circumstances in connection with a superior proposal received prior to the end of the go-shop period, (v) a termination fee payable by the Company equal to 2.0% of the Company’s fully diluted equity value based on the per share price if the Merger Agreement was terminated under certain other circumstances, (vi) a termination fee payable by the potential acquiror equal to 10.0% of the Company’s fully diluted equity value based on the per share price if the Merger Agreement was terminated under certain other circumstances and (vii) a “hell-or-high-water” regulatory efforts covenant applicable to the potential acquiror and its affiliates.

Between June 25, 2024 and July 3, 2024, members of the Company’s senior management and representatives of J.P. Morgan participated in several additional due diligence sessions with KKR and its representatives.

On June 26, 2024, the Transaction Committee convened to discuss the status of diligence and the remaining high priority requests.

26

On June 27, 2024, a representative of KKR submitted a written indication of interest to J.P. Morgan re-affirming KKR’s June 24, 2024 verbal proposal to acquire all of the outstanding shares of Company Common Stock for $24.50 per share, subject to satisfactory completion of outstanding diligence and assuming the ability of KKR to syndicate a portion of the equity financing to co-investors at such price. KKR’s written indication of interest represented a 21% premium to the Company’s unaffected share price of $20.27 as of May 17, 2024, the last trading day prior to the Reuters Article.

On July 2, 2024, the Board convened a meeting with members of the Company’s management, representatives of K&E and J.P. Morgan in attendance. Representatives of J.P. Morgan, the Board and Company management discussed the outreach conducted on behalf of the Company and unsolicited inbound interest to date, that KKR, Party E and Party F were the only parties that had submitted non-binding indications of interest with respect to a potential acquisition of all of the outstanding shares of the Company Common Stock (which non-binding indications of interest had previously been provided or communicated to the Board), and that all of such parties satisfied certain key metrics previously determined by the Board for potentially participating in a process, including that: (i) such parties were familiar with the Company’s business and the industries in which the Company operates and (ii) such parties had sufficient financial capacity to provide the equity financing necessary to consummate a potential transaction. Representatives of J.P. Morgan, the Board and Company management then discussed (A) the fact that, in spite of the Company’s efforts to engage with potential strategic buyers, no such strategic buyers had indicated an interest in continuing participation in a process at that time, (B) Party F was no longer interested in pursuing a potential transaction and (C) Party E had verbally indicated that their bid would likely be lower than the range provided in their indication of interest. Based on these discussions, the Board determined that only KKR would be moving forward as a potential acquiror in a proposed transaction. Representatives of J.P. Morgan then presented to the Board regarding certain preliminary financial analyses prepared by J.P. Morgan and J.P. Morgan also provided a relationship disclosure letter to the Board, which provided customary relationship disclosures with respect to the Company, Thoma Bravo and KKR. The Board was then presented with an opportunity to ask questions regarding the disclosure letter. Representatives of K&E provided an overview of fiduciary duties under Delaware law specifically in the context of mergers and acquisitions and presented an overview of process considerations that the Board should take into account when evaluating a potential sale transaction, including evaluation of the Company’s standalone plan. Representatives of K&E then orally disclosed to the Board relationships of K&E, including certain representatives of K&E, with the Company, Thoma Bravo, KKR and other relevant parties, which included, among other things, the fact that Thoma Bravo and KKR are long-standing clients of K&E with multiple concurrent engagements and that certain partners of K&E are members of a limited partnership that is an investor in one or more investment funds affiliated with Thoma Bravo and KKR, but that no attorney of K&E was representing KKR in the proposed transaction between the Company and KKR. Following K&E’s oral disclosure, the Board concluded that none of the relationships disclosed would affect K&E’s ability to serve as the Company’s legal advisor. After a fulsome discussion, including weighing the proposals against the Company’s standalone plan, the Board (1) authorized the Transaction Committee to continue negotiations with KKR on behalf of the Board, (2) authorized the Company to execute an engagement letter with J.P. Morgan subject to approval of the economic terms and (3) ratified the Transaction Committee’s prior approval permitting KKR to discuss the potential transaction with debt and equity financing sources. After the Board meeting and at the direction of the Board, representatives of J.P. Morgan notified Party E that they would not be moving forward in the process.

On July 2, 2024, outside legal counsel to KKR, Simpson Thacher & Bartlett LLP (“Simpson”), sent K&E a revised draft of the Merger Agreement. This draft of the Merger Agreement, among other changes, (i) removed the go-shop provision, (ii) proposed a Company termination fee of 3.50% of the fully diluted equity value of the Company based on the per share price if the Merger Agreement was terminated under certain circumstances in connection with a superior proposal received prior to the receipt of the written consent approving the merger, (iii) proposed an acquiror termination fee of 4.50% of the fully diluted equity value of the Company based on the per share price, (iv) excluded Parent’s affiliates from the “hell-or-high-water” regulatory efforts covenant and (v)

27

provided that the Principal Stockholders would deliver a written consent shortly after execution of the Merger Agreement, meaning there would be no meaningful period of time when the Board would have a “fiduciary out” if a superior proposal emerged.

On July 6, 2024, representatives of Simpson delivered to representatives of K&E an initial draft of the Equity Commitment Letter and Limited Guarantee (each as defined in “—Financing” beginning on page 44) to be executed by an investment fund affiliated with KKR in connection with the proposed transaction.

On July 9, 2024, K&E sent Simpson a revised draft of the Merger Agreement and between July 9 and July 25 2024, K&E and Simpson, on behalf of the Company and KKR, respectively, exchanged drafts of the Merger Agreement and conducted a number of conference calls regarding the Merger Agreement. During this period of time the parties continued to negotiate the Merger Agreement, including, among other items, (i) the go-shop provision, (ii) the efforts required by the Company and Parent to obtain the required regulatory approvals, including restrictions on Parent from entering into transactions that would reasonably be expected to delay the consummation of the Merger and restrictions on actions of the acquiror that would trigger any additional government clearances, consents, approvals, waivers or actions and (iii) the termination fees payable by the Company and Parent in the event the Merger Agreement was terminated under certain circumstances.

On July 10, 2024, members of the Company’s senior management hosted representatives of KKR at the Company’s industry conference in Las Vegas, during which the parties engaged in additional diligence discussions.

On July 13, 2024, K&E sent Simpson a draft of the Disclosure Schedules to the Merger Agreement (the “Disclosure Schedules”). Between July 13 and July 25, 2024, K&E and Simpson exchanged drafts of the Disclosure Schedules.

On July 14, 2024, representatives of J.P. Morgan introduced representatives of KKR to representatives of Dragoneer over email. Later on July 14, 2024, Dragoneer executed a joinder to the confidentiality agreement previously signed by KKR and was provided access to the Company’s data room for bidders.

On July 15, 2024, Mr. Jaffee provided an email update to the Board with respect to the status of discussions with KKR, including with respect to their diligence and progress negotiating the Merger Agreement and other transaction documents.

On July 15, 2024, representatives of Thoma Bravo, KKR and J.P. Morgan held a discussion regarding potential third-party equity financing sources that KKR was seeking permission to contact and KKR provided an update on the status of its process to secure a portion of the equity financing. On July 15, 2024, representatives of KKR had an initial meeting with representatives of Dragoneer and continued discussions over the next several days regarding terms of a potential equity co-investment by Dragoneer.

On July 15, 2024, representatives of Simpson delivered to representatives of K&E a draft of the Debt Commitment Letter contemplating the Debt Financing (each as defined in “—Financing” beginning on page 44).

On July 16, 2024, representatives of Thoma Bravo met with Dragoneer’s investment team to further discuss the co-invest opportunity and provide an update on the status and details of the potential transaction. At this meeting, representatives of Thoma Bravo provided responses to due diligence questions from representatives of Dragoneer regarding the potential transaction and the Company.

On July 17, 2024, J.P. Morgan provided updated relationship disclosures regarding the Company, Thoma Bravo and KKR to the Board. Later on July 17, 2024, the Board convened a meeting with the Company’s management, with representatives of K&E and J.P. Morgan in attendance. J.P. Morgan, the Board and the Company’s management discussed the due diligence process in connection with the potential strategic

28

transaction with KKR, including the additional several meetings that had occurred in recent weeks, the key diligence work that had been completed since July 2, 2024 and the key diligence requests that remained outstanding. Representatives of J.P. Morgan then presented to the Board regarding certain preliminary financial analyses prepared by J.P. Morgan. Representatives from J.P. Morgan, the Company’s management and the Board then reviewed the potential timeline to announcement and closing of a transaction. Questions were asked and answered, and a full discussion ensued. Representatives of K&E discussed with the members of the Board their fiduciary duties in connection with the potential transaction with KKR and presented an update with respect to outstanding issues in the Merger Agreement and other transaction documents. K&E also provided an update with respect to KKR’s debt financing in connection with the Merger and a related estimated timeline. J.P. Morgan left the meeting and K&E then discussed the key terms of the Company’s engagement with J.P. Morgan, including the transaction fees associated with the potential Merger and the opinion fees associated with J.P. Morgan rendering a fairness opinion, among other engagement letter terms, and the Board reviewed and approved the updated relationship disclosures.

On July 18, Mr. Daly and other members of the Company’s senior management gave a management presentation to representatives of Dragoneer and KKR to facilitate Dragoneer’s evaluation of potentially providing equity financing to KKR.

On July 19, 2024, Mr. Jaffee and a representative of KKR spoke to discuss the status of the transaction and the related equity financing. The representative of KKR indicated that KKR had not yet obtained equity commitments necessary for the acquisition, but they would continue to engage with a few of their larger limited partners and would revert on July 23, 2024 with an updated status following a meeting with their investment committee on July 22, 2024.

On July 21, 2024. Mr. Spaht had a call with a representative of KKR to discuss the status of the potential transaction and the representative of KKR indicated that KKR’s internal processes were progressing as expected in advance of KKR’s investment committee meeting the next day.

On July 23, 2024, a representative of KKR called Mr. Jaffee to convey that KKR was still having difficulty finding co-investors willing to provide a portion of the equity financing at a price equal to $24.50 per share and that KKR would need to reduce its offer to acquire all of the outstanding shares of Company Common Stock to $23.25 per share, representing a 14.7% premium to the Company’s unaffected share price of $20.27 as of May 17, 2024, the last trading day prior to the Reuters Article.

Later on July 23, 2024, in response to KKR’s reduced offer, Mr. Spaht, on behalf of the Transaction Committee, called representatives of KKR to convey that he expected the Board would be unwilling to proceed at the price indicated in KKR’s July 23rd proposal but, subject to discussion with the Board, the Board may support a price of $24.00 per share. Representatives of KKR then countered with an offer of $23.50 per share. Mr. Spaht indicated to representatives of KKR that a price per share of $23.50 was also insufficient. After further discussion, KKR verbally made an offer to acquire all of the outstanding shares of Company Common Stock for $23.60 per share, representing a 16.4% premium to the Company’s unaffected share price of $20.27 as of May 17, 2024, the last trading day prior to the Reuters Article, which KKR indicated was its last and final offer. Mr. Spaht indicated that he would discuss the offer with the Board.

On July 23, 2024, J.P. Morgan provided an updated relationship disclosure letter to the Board, which provided customary relationship disclosures with respect to the Company, Thoma Bravo, KKR and Dragoneer and the Board reviewed and approved such updated relationship disclosures.

On July 23, 2024, pursuant to an earlier discussion between representatives of J.P. Morgan and Mr. Walker regarding the preparation of unlevered free cash flow projections through 2033 based on extrapolations of the Management Forecasts (the unlevered free cash flow projections extending through 2033 are included in the “Expanded Forecasts” as discussed in further detail in the section of this information statement entitled “—Certain

29

Company Financial Forecasts” beginning on page 41), the Company’s management approved the Expanded Forecasts for use by J.P. Morgan in connection with its financial analyses and opinion.

On July 24, 2024, as a result of the aforementioned discussions and after several exchanges of revised drafts of the Merger Agreement and other transaction documents since the July 9, 2024 draft K&E shared with Simpson, K&E received a revised draft of the Merger Agreement from Simpson proposing, among other things, (i) to replace the 25-day go-shop provision in K&E’s prior proposal with a customary “no-shop” provision, (ii) an acquiror termination fee of 6.0% of the fully diluted equity value of the Company based on the Per Share Price in response to K&E’s prior proposal in an earlier draft of the Merger Agreement of 7.0%, (iii) certain changes with respect to the effort required of the acquiror to obtain regulatory approvals for the transaction, and (iv) to require the delivery of a written consent by the Principal Stockholders promptly following the execution of the definitive Merger Agreement.

On July 24, 2024, the Board held a meeting with members of the Company’s management and representatives of J.P. Morgan and K&E in attendance. Members of the Board and management and representatives of J.P. Morgan updated the Board with respect to the revised terms proposed by KKR and the negotiations that had occurred over the last several days and a discussion ensued. Representatives of J.P. Morgan then reviewed the financial aspects of the proposed Merger and provided the Board with an update of its preliminary financial analyses with respect to the Company, and members of the Company’s management discussed with the Board the Expanded Forecasts, including the material assumptions included therein. For a detailed discussion regarding the Expanded Forecasts, please see “—Certain Company Financial Forecasts.” Representatives of K&E summarized the terms of the draft Merger Agreement received from Simpson earlier that day, including with respect to (i) the efforts the acquiror was required to take to obtain regulatory approvals and that before receipt of required antitrust approvals the acquiror was prohibited from entering into transactions that would reasonably be expected to prevent or materially delay receipt of required antitrust approvals for the transaction, (ii) the amount of the termination fee payable by the Company in certain circumstances, and (iii) the amount of the termination fee payable by the acquiror in certain circumstances. The Board discussed the price of $23.60 per share and other terms of the Merger Agreement, and indicated its support for a transaction on those terms in light of the Company’s standalone prospects and outlook, subject to review of the final Merger Agreement and other transaction documents.

During the course of the evening of July 24, 2024 and overnight, K&E and Simpson worked to finalize the Merger Agreement, Disclosure Schedules, Equity Commitment Letter, Debt Commitment Letter, Limited Guaranty and other transaction documents.

Early in the morning of July 25, 2024, the parties completed their negotiation of the Merger Agreement, Disclosure Schedules, Equity Commitment Letter, Debt Commitment Letter, Limited Guaranty and other transaction documents and had agreed to resolve the open issues in the Merger Agreement largely in the manner proposed by Simpson on July 24, 2024.

Early in the morning of July 25, 2024 and following the finalization of the transaction documents, the Board held a meeting with members of the Company’s management and representatives of J.P. Morgan and K&E in attendance. Representatives of K&E summarized the proposed final terms of the Merger Agreement which were consistent with the terms discussed at the July 24, 2024 meeting and discussed with the Board its fiduciary duties under Delaware law in connection with the potential transaction. J.P. Morgan then reviewed with the Board its final financial analyses with respect to the Company and, thereafter, delivered its oral opinion (which J.P. Morgan subsequently confirmed in writing) that, as of such date and based upon and subject to the factors and assumptions set forth therein, the consideration to be paid to the holders of Company Common Stock in the Merger was fair, from a financial point of view, to such holders. J.P. Morgan’s opinion is more fully described in the section of this information statement entitled “—Opinion of J.P. Morgan.” Following discussion and consideration of the Merger Agreement and the other transactions contemplated by the Merger Agreement (including the factors described in the section titled “—Reasons for the Merger; Recommendation of the Board”),

30

the members of the Board unanimously: (i) determined that the terms of the Merger Agreement and related transactions are fair to and in the best interests of the holders of Company Common Stock, and declared it advisable, to enter into the Merger Agreement providing for the Merger in accordance with the DGCL; (ii) approved the execution and delivery of the Merger Agreement by the Company, the performance by the Company of its covenants and other obligations under the Merger Agreement, and the consummation of the Merger upon the terms and subject to the conditions set forth in the Merger Agreement; and (iii) resolved to recommend that the holders of Company Common Stock adopt the Merger Agreement. Further, the members of the Board reviewed and approved the Equity Commitment Letter, the Limited Guaranty, the Disclosure Schedules and other transaction documents.

Thereafter, the Company and the acquiror executed the Merger Agreement and KKR delivered an executed Equity Commitment Letter, Debt Commitment Letter and Limited Guaranty. Following the execution of the Merger Agreement and related transaction documents, the Company and KKR issued a joint press release announcing the entry into the Merger Agreement before the opening of the U.S. stock exchange on July 25, 2024. Thoma Bravo, as holder of approximately 83.3% of the aggregate voting power of the issued and outstanding shares of Company Common Stock, delivered a stockholder action by written consent approving the Merger later that day.

Recommendation of the Board; Reasons for the Merger

After careful consideration, the Board unanimously:

In the course of the Board making such determinations, the Board consulted with management of Instructure, as well as Instructure’s legal and financial advisors, and considered the following potentially positive factors, which are not intended to be exhaustive and are not presented in any relative order of importance:

31

32

33

The Board also considered and balanced against the potentially positive factors a number of potentially negative factors concerning the Merger, including the following factors:

34

During its consideration of the transaction with KKR, the Board was also aware of and considered that Instructure’s directors and executive officers may have interests in the Merger that differ from, or are in addition to, the interests of Instructure’s stockholders generally, as described under “The Merger—Interests of Our Directors and Executive Officers in the Merger” beginning on page 44.

After taking into account all of the factors set forth above, as well as others, the Board determined that the potentially positive factors outweighed the potentially negative factors. The foregoing discussion of the factors considered by the Board is not intended to be exhaustive, but summarizes the material information and factors considered by the Board in its consideration of the Merger. The Board reached the decision to recommend and approve the Merger Agreement, the Merger and the other transactions contemplated by the Merger Agreement, in light of the factors described above and other factors the Board felt were appropriate. In view of the variety of factors and the quality and amount of information considered, the Board did not find it practicable to and did not quantify or otherwise assign relative weights to the specific factors considered in reaching its determination and individual members of the Board may have given different weights to different factors. The Board conducted an overall analysis of the factors described above, including thorough discussions with, and questioning of, senior management of Instructure, J.P. Morgan and Macquarie Capital as financial advisors, and K&E as legal advisor, and considered the factors overall to be favorable to, and to support, its determinations. This explanation of the reasoning of the Board and certain information presented in this section is forward-looking in nature and should be read in light of the factors set forth in “Cautionary Statement Regarding Forward-Looking Statements” beginning on page 18.

Required Stockholder Approval for the Merger

Under Delaware law and Instructure’s certificate of incorporation, the adoption of the Merger Agreement by our stockholders required the affirmative vote or written consent of stockholders of Instructure holding in the aggregate at least a majority of the voting power of the outstanding shares of Company Common Stock entitled to vote thereon. As of July 25, 2024, the record date for determining stockholders of Instructure entitled to vote on the adoption of the Merger Agreement, there were 146,471,276 shares of Company Common Stock outstanding. Holders of Company Common Stock are entitled to one vote for each share held of record on all matters on which stockholders are entitled to vote generally, including adoption of the Merger Agreement.

On July 25, 2024, immediately following the execution of the Merger Agreement, the Principal Stockholders, which together on July 25, 2024 beneficially owned 122,065,804 shares of Company Common Stock representing approximately 83.3% of the aggregate voting power of the then issued and outstanding shares of Company Common Stock, delivered the Written Consent. As a result, no further action by any stockholder of Instructure is required under applicable law or the Merger Agreement (or otherwise) to adopt the Merger Agreement, and Instructure will not be soliciting your vote for or consent to the adoption of the Merger Agreement and the approval of the transactions contemplated by the Merger Agreement and will not call a stockholders’ meeting for purposes of voting on the adoption of the Merger Agreement and the approval of the transactions contemplated by the Merger Agreement. No action by the stockholders of Parent is required to complete the Merger and all requisite corporate action by and on behalf of Merger Sub required to complete the Merger has been taken.

When actions are taken by the written consent of less than all of the stockholders entitled to vote on a matter, Delaware law requires notice of the action be given to those stockholders who did not consent in writing to the action and who, if the action had been taken at a meeting, would have been entitled to notice of the meeting if the record date for notice of such meeting had been the date that consents signed by a sufficient number of holders to take the action were delivered to the corporation in accordance with Section 228 of the DGCL. This information statement and the notice attached hereto constitute notice to you from Instructure of the Written Consent as required by Delaware law.

35

Opinion of J.P. Morgan

Pursuant to an engagement letter, the Company retained J.P. Morgan as its financial advisor in connection with the Merger.

At the meeting of the Board on July 25, 2024, J.P. Morgan rendered its oral opinion to the Board that, as of such date and based upon and subject to the factors and assumptions set forth in its opinion, the consideration to be paid to the holders of Company Common Stock in the Merger was fair, from a financial point of view, to such holders. J.P. Morgan has confirmed its July 25, 2024 oral opinion by delivering its written opinion to the Board, dated July 25, 2024, that, as of such date, the consideration to be paid to the holders of Company Common Stock in the Merger was fair, from a financial point of view, to such holders.

The full text of the written opinion of J.P. Morgan dated July 25, 2024, which sets forth, among other things, the assumptions made, matters considered and limits on the review undertaken, is attached as Annex B to this information statement and is incorporated herein by reference. The summary of the opinion of J.P. Morgan set forth in this information statement is qualified in its entirety by reference to the full text of such opinion. The Company’s stockholders are urged to read the opinion in its entirety.

J.P. Morgan’s written opinion was addressed to the Board (in its capacity as such) in connection with and for the purposes of its evaluation of the Merger, and addressed, as of the date of the opinion, the fairness, from a financial point of view, of the consideration to be paid to holders of Company Common Stock in the Merger and did not address any other aspect of the Merger. J.P. Morgan expressed no opinion as to the fairness of the consideration to the holders of any class of securities, creditors or other constituencies of the Company or as to the underlying decision by the Company to engage in the Merger. The issuance of J.P. Morgan’s opinion was approved by a fairness committee of J.P. Morgan. The opinion does not constitute a recommendation to any stockholder of the Company as to how such stockholder should vote with respect to the Merger or any other matter.

In arriving at its opinion, J.P. Morgan, among other things:

In addition, J.P. Morgan held discussions with certain members of the management of the Company and Parent with respect to certain aspects of the Merger, and the past and current business operations of the Company, the financial condition and future prospects and operations of the Company and certain other matters J.P. Morgan believed necessary or appropriate to its inquiry.

In giving its opinion, J.P. Morgan relied upon and assumed the accuracy and completeness of all information that was publicly available or was furnished to or discussed with J.P. Morgan by the Company or

36

otherwise reviewed by or for J.P. Morgan, and J.P. Morgan did not independently verify (and did not assume responsibility or liability for independently verifying) any such information or its accuracy or completeness. J.P. Morgan did not conduct or was not provided with any valuation or appraisal of any assets or liabilities, nor did J.P. Morgan evaluate the solvency of the Company or Parent under any state or federal laws relating to bankruptcy, insolvency or similar matters. In relying on financial analyses and forecasts provided to J.P. Morgan or derived therefrom, J.P. Morgan assumed that they were reasonably prepared based on assumptions reflecting the best currently available estimates and judgments by management as to the expected future results of operations and financial condition of the Company to which such analyses or forecasts relate. J.P. Morgan expressed no view as to such analyses or forecasts or the assumptions on which they were based. J.P. Morgan also assumed that the Merger and the other transactions contemplated by the Merger Agreement will be consummated as described in the Merger Agreement, and that the definitive Merger Agreement would not differ in any material respect from the draft thereof furnished to J.P. Morgan. J.P. Morgan also assumed that the representations and warranties made by the Company, Parent, and Merger Sub in the Merger Agreement and the related agreements were and will be true and correct in all respects material to its analysis. J.P Morgan is not a legal, regulatory or tax expert and relied on the assessments made by advisors to the Company with respect to such issues. J.P. Morgan further assumed that all material governmental, regulatory or other consents and approvals necessary for the consummation of the Merger will be obtained without any adverse effect on the Company or on the contemplated benefits of the Merger.

The projections furnished to J.P. Morgan were prepared by the Company’s management. The Company does not publicly disclose internal management projections of the type provided to J.P. Morgan in connection with J.P. Morgan’s analysis of the Merger, and such projections were not prepared with a view toward public disclosure. These projections were based on numerous variables and assumptions that are inherently uncertain and may be beyond the control of the Company’s management, including, without limitation, factors related to general economic and competitive conditions and prevailing interest rates. Accordingly, actual results could vary significantly from those set forth in such projections.

J.P. Morgan’s opinion was necessarily based on economic, market and other conditions as in effect on, and the information made available to J.P. Morgan as of, the date of such opinion. J.P. Morgan’s opinion noted that subsequent developments may affect J.P. Morgan’s opinion, and that J.P. Morgan does not have any obligation to update, revise, or reaffirm such opinion. J.P. Morgan’s opinion is limited to the fairness, from a financial point of view, of the consideration to be paid to the holders of Company Common Stock in the Merger, and J.P. Morgan has expressed no opinion as to the fairness of any consideration to the holders of any other class of securities, creditors or other constituencies of the Company or the underlying decision by the Company to engage in the Merger. Furthermore, J.P. Morgan expressed no opinion with respect to the amount or nature of any compensation to any officers, directors, or employees of any party to the Merger, or any class of such persons relative to the Merger consideration in the Merger or with respect to the fairness of any such compensation.

The terms of the Merger Agreement were determined through arm’s length negotiations between the Company and Parent, and the decision to enter into the Merger Agreement was solely that of the Board. J.P. Morgan’s opinion and financial analyses were only one of the many factors considered by the Board in its evaluation of the Merger and should not be viewed as determinative of the views of the Board or management with respect to the Merger or the Merger consideration.

In accordance with customary investment banking practice, J.P. Morgan employed generally accepted valuation methodology in rendering its opinion to the Board on July 25, 2024 and contained in the presentation delivered to the Board on such date in connection with the rendering of such opinion and does not purport to be a complete description of the analyses or data presented by J.P. Morgan. Some of the summaries of the financial analyses include information presented in tabular format. The tables are not intended to stand alone, and in order to more fully understand the financial analyses used by J.P. Morgan, the tables must be read together with the full text of each summary. Considering the data set forth below without considering the full narrative description of the financial analyses, including the methodologies and assumptions underlying the analyses, could create a misleading or incomplete view of J.P. Morgan’s analyses.

37

Public Trading Multiples. Using publicly available information, J.P. Morgan compared selected financial data of the Company with similar data for selected publicly traded companies engaged in businesses which J.P. Morgan judged to be analogous to the Company. The companies selected by J.P. Morgan were:

These companies were selected, among other reasons, because they are publicly traded companies with operations and businesses that, for purposes of J.P. Morgan’s analysis, may be considered similar to those of the Company. However, certain of these companies may have characteristics that are materially different from those of the Company. The analyses necessarily involve complex considerations and judgments concerning differences in financial and operational characteristics of the companies involved and other factors that could affect the selected companies differently than they would affect the Company.

Using information obtained from the selected companies’ public filings and FactSet Research Systems as of July 24, 2024, J.P. Morgan calculated, for each selected company, the ratios of the company’s firm value (“FV”) to the consensus equity research analyst estimates for the company’s earnings before interest, taxes, depreciation and amortization, excluding stock based compensation and certain non-recurring items of a significant or unusual nature, as applicable (“Adj. EBITDA”) for the year ending December 31, 2025 (the “FV/2025E Adj. EBITDA”).

Based on the results of this analysis, J.P. Morgan selected a reference range of 11.0x – 17.0x for FV/2025E Adj. EBITDA for the Company. After applying such ranges to the projected Adj. EBITDA for the Company for the twelve-month period ending December 31, 2025, as provided by the Company’s management, the analysis indicated the following ranges of implied per share equity value (rounded to the nearest $0.25) for Company Common Stock:

The ranges of implied per share equity values for Company Common Stock were compared to the Merger consideration of $23.60 per share of Company Common Stock.

Selected Transaction Analysis. Using publicly available information, J.P. Morgan examined selected transactions involving businesses which J.P. Morgan judged to be similar to the Company’s business (or aspects thereof) based on J.P. Morgan’s experience and familiarity with the industries in which the Company operates. Specifically, J.P. Morgan reviewed the following transactions:

38

None of the selected transactions reviewed was identical to the proposed Merger. However, the selected transactions were chosen because their participants, size and other factors, for purposes of J.P. Morgan’s analysis, may be considered similar to the Merger. The analyses necessarily involve complex considerations and judgments concerning differences in financial and operational characteristics of the companies involved and other factors that could affect the transactions differently than they would affect the Merger.

Using publicly available information, J.P. Morgan calculated, for each selected transaction, the ratio of the target company’s FV implied by the consideration to be paid for the target company in such transaction as a multiple of published equity research analyst estimates for the target company’s projected revenue for the twelve-month period immediately following the announcement of each transaction (the “FV/NTM Revenue”).

Based on the results of this analysis and other factors J.P. Morgan considered appropriate based on its experience and professional judgment, J.P. Morgan selected a multiple reference range for FV/NTM Revenue of 4.5x to 7.5x. After applying each range to the Company’s estimated revenue for the twelve-month period immediately following June 30, 2024, as provided by the Company’s management, the analysis indicated the following ranges of implied per share equity value (rounded to the nearest $0.25) for the Company Common Stock:

The ranges of implied per share equity value for the shares of Company Common Stock was compared to the Merger consideration of $23.60 per share of Company Common Stock.

Discounted Cash Flow Analysis. J.P. Morgan conducted a discounted cash flow analysis for the purpose of determining the fully diluted equity value per share for the Company Common Stock. J.P. Morgan calculated the unlevered free cash flows that the Company is expected to generate during fiscal years 2024 through 2033 based upon financial projections approved by Company management for the years ended 2024 through 2033. J.P. Morgan also calculated a range of terminal asset values of the Company at the end of the 10-year period ending 2033 by applying a perpetual growth rate ranging from 2.5% to 3.5% of the unlevered free cash flow of the Company during the final year of the 10-year period. The unlevered free cash flows and the range of terminal asset values were then discounted to present values using a range of discount rates from 9.0% to 11.0%, which were chosen by J.P. Morgan based upon an analysis of the weighted average cost of capital of the Company. The present value of the unlevered free cash flows and the range of terminal asset values were then adjusted by subtracting the net debt for the Company as of June 30, 2024.

Based on the foregoing, this analysis indicated the following range of implied per share equity value for Company Common Stock (rounded to the nearest $0.25):

The ranges of implied per share equity values for Company Common Stock were compared to the Merger consideration of $23.60 per share of Company Common Stock.

39

Miscellaneous. The foregoing summary of certain material financial analyses does not purport to be a complete description of the analyses or data presented by J.P. Morgan. The preparation of a fairness opinion is a complex process and is not necessarily susceptible to partial analysis or summary description. J.P. Morgan believes that the foregoing summary and its analyses must be considered as a whole and that selecting portions of the foregoing summary and these analyses, without considering all of its analyses as a whole, could create an incomplete view of the processes underlying the analyses and its opinion. As a result, the ranges of valuations resulting from any particular analysis or combination of analyses described above were merely utilized to create points of reference for analytical purposes and should not be taken to be the view of J.P. Morgan with respect to the actual value of the Company. The order of analyses described does not represent the relative importance or weight given to those analyses by J.P. Morgan. In arriving at its opinion, J.P. Morgan did not attribute any particular weight to any analyses or factors considered by it and did not form an opinion as to whether any individual analysis or factor (positive or negative), considered in isolation, supported or failed to support its opinion. Rather, J.P. Morgan considered the totality of the factors and analyses performed in determining its opinion.

Analyses based upon forecasts of future results are inherently uncertain, as they are subject to numerous factors or events beyond the control of the parties and their advisors. Accordingly, forecasts and analyses used or made by J.P. Morgan are not necessarily indicative of actual future results, which may be significantly more or less favorable than suggested by those analyses. Moreover, J.P. Morgan’s analyses are not and do not purport to be appraisals or otherwise reflective of the prices at which businesses actually could be acquired or sold. None of the selected companies reviewed as described in the above summary is identical to the Company, and none of the selected transactions reviewed was identical to the Merger. However, the companies selected were chosen because they are publicly traded companies with operations and businesses that, for purposes of J.P. Morgan’s analysis, may be considered similar to those of the Company. The transactions selected were similarly chosen because their participants, size and other factors, for purposes of J.P. Morgan’s analysis, may be considered similar to the Merger. The analyses necessarily involve complex considerations and judgments concerning differences in financial and operational characteristics of the companies involved and other factors that could affect the companies compared to the Company and the transactions compared to the Merger.

As a part of its investment banking business, J.P. Morgan and its affiliates are continually engaged in the valuation of businesses and their securities in connection with mergers and acquisitions, investments for passive and control purposes, negotiated underwritings, secondary distributions of listed and unlisted securities, private placements, and valuations for corporate and other purposes. J.P. Morgan was selected to advise the Company with respect to the Merger on the basis of, among other things, such experience and its qualifications and reputation in connection with such matters and its familiarity with the Company and the industries in which it operates.

For financial advisory services rendered in connection with the Merger, the Company has agreed to pay J.P. Morgan a fee of approximately $38.5 million, of which $3.0 million became payable upon delivery of its opinion and the remainder of which is contingent and payable upon the closing of the Merger. In addition, the Company has agreed to reimburse J.P. Morgan for its expenses incurred in connection with its services, including the fees and disbursements of counsel, and will indemnify J.P. Morgan against certain liabilities arising out of J.P. Morgan’s engagement. During the two years preceding the date of J.P. Morgan’s opinion, J.P. Morgan and its affiliates have had and continue to have commercial or investment banking relationships with the Company and Thoma Bravo, the Company’s approximately 83% shareholder, for which J.P. Morgan and such affiliates have received or will receive customary compensation. Such services during such period for the Company have included acting as joint lead arranger and bookrunner on a credit facility in February 2024 and financial advisor to the Company on its acquisition of Parchment in February 2024. Such services during such period have also included providing debt syndication, equity underwriting and financial advisory services to Thoma Bravo portfolio companies. During the two years preceding the date of J.P. Morgan’s opinion, neither J.P. Morgan nor its affiliates have had any other material financial advisory or other material commercial or investment banking relationships with Dragoneer. During the two years preceding the date of J.P. Morgan’s opinion, J.P. Morgan and

40

its affiliates have had and continue to have commercial or investment banking relationships with KKR & Co. Inc. (“KKR & Co.”), an affiliate of Parent, for which J.P. Morgan and its affiliates have received or will receive customary compensation. Such services during such period have included acting as joint lead arranger and bookrunner on credit facilities of a KKR & Co. affiliate in July 2022 and May 2024 and financial advisor to an affiliate of KKR & Co. on its acquisition of ContourGlobal in December 2022. In addition, during the two years preceding the date of J.P. Morgan’s opinion, J.P. Morgan and its affiliates have had and continue to have commercial or investment banking relationships with portfolio companies of KKR & Co., for which J.P. Morgan and its affiliates have received or will receive customary compensation. Such services during such period have included providing debt syndication, equity underwriting, debt underwriting and financial advisory services to KKR & Co. portfolio companies. In addition, J.P. Morgan’s commercial banking affiliate is an agent bank and a lender under outstanding credit facilities of the Company, an affiliate of KKR & Co., and portfolio companies of each of Thoma Bravo and KKR & Co., for which it receives customary compensation or other financial benefits. In addition, J.P. Morgan and its affiliates hold, on a proprietary basis, approximately 0.05%, 0.00%, 0.00% and 0.00% of the outstanding common stock of each of KKR & Co., Dragoneer, the Company and Thoma Bravo, respectively. During the two-year period preceding delivery of its opinion, the aggregate fees recognized by J.P. Morgan from the Company were approximately $5.4 million, from Thoma Bravo and its controlled portfolio companies were approximately $54.4 million, and from KKR & Co. and its controlled portfolio companies were approximately $81.6 million. During the two-year period preceding delivery of its opinion, J.P. Morgan did not recognize any fees from Dragoneer. As of the date of its opinion, J.P. Morgan and its affiliates are providing investment banking services to Thoma Bravo and/or its affiliates, which services are unrelated to the Merger. J.P. Morgan expects to receive customary compensation in connection with the foregoing which, considered in the aggregate and assuming such transactions are actually completed, are expected by J.P. Morgan to be greater than the fees it would receive from the Company in the Merger. In addition, as of the date of the information statement, J.P. Morgan and its affiliates are providing investment banking services to KKR & Co. and/or its affiliates, which services are unrelated to the Merger. J.P. Morgan expects to receive customary compensation in connection with the foregoing which, considered in the aggregate and assuming such transactions are actually completed, are expected by J.P. Morgan to be materially greater than the fees J.P. Morgan would receive from the Company in the Merger. In the ordinary course of their businesses, J.P. Morgan and its affiliates actively trade the debt and equity securities or financial instruments (including derivatives, bank loans or other obligations) of the Company and KKR & Co. for J.P. Morgan’s own accounts or for the accounts of customers and, accordingly, they are likely to hold at any time long or short positions in such securities or other financial instruments.

Certain Company Financial Forecasts

Instructure does not generally publish its business plans and strategies or make external disclosures of its anticipated financial position or results of operations other than for providing, from time to time, estimates of certain expected financial results and operational metrics in its regular annual and quarterly earnings press releases and other investor materials.

Instructure is especially wary of making financial forecasts for extended earnings periods because of the unpredictability of the underlying assumptions and estimates and does not prepare five-year or ten-year forecasts of the type described below in the ordinary course of business. However, in connection with its evaluation of the Merger, the Board reviewed and approved, among other things, the Management Forecasts developed by Instructure’s management with respect to fiscal years 2024 through 2028. The Board was also provided with the Expanded Forecasts approved by Instructure’s management with respect to fiscal years 2024 through 2033 that were developed based on extrapolations of the Management Forecasts (the Expanded Forecasts together with the Management Forecasts, the “Financial Forecasts”).

The Financial Forecasts included in this information statement are subjective in many respects. The Financial Forecasts were not prepared with a view to public disclosure and the Management Forecasts are included in this information statement only because such information was made available to the Board, J.P.

41

Morgan and Parent as described herein and the Expanded Forecasts are included in this information statement only because such information was used by J.P. Morgan in connection with its financial analyses and opinion and made available to the Board. The Financial Forecasts were not prepared with a view to compliance with generally accepted accounting principles as applied in the United States, which we refer to herein as “GAAP,” the published guidelines of the SEC regarding projections and forward-looking statements or the guidelines established by the American Institute of Certified Public Accountants for preparation and presentation of prospective financial information. Furthermore, the Financial Forecasts do not take into account any circumstances or events occurring after the date they were prepared, including the Merger. The Financial Forecasts are not fact and should not be relied upon as being necessarily indicative of future results, and readers of this information statement are cautioned not to place undue reliance on this information. Although this summary of the Financial Forecasts is presented with numerical specificity, the forecasts reflect numerous variables, assumptions and estimates as to future events made by Instructure’s management that Instructure’s management believed were reasonable at the time the Management Forecasts were prepared, taking into account the relevant information available to management at the time. However, such variables, assumptions and estimates are inherently uncertain, and many are beyond the control of Instructure’s management. Because the Financial Forecasts cover multiple years, by their nature, they become subject to greater uncertainty with each successive year. The Financial Forecasts reflect numerous estimates and assumptions with respect to industry performance, general business, economic, regulatory, market and financial conditions and other future events, as well as matters specific to Instructure’s business, all of which are difficult to predict and many of which are beyond Instructure’s control. As a result, the Financial Forecasts may not be realized and actual results may be significantly higher or lower than projected. The Financial Forecasts are subjective in many respects and thus are susceptible to multiple interpretations and periodic revisions based on actual experience and business developments.

As such, the Financial Forecasts constitute forward-looking information and are subject to risks and uncertainties, including the various risks set forth in Instructure’s Annual Report on Form 10-K for the year ended December 31, 2023, Instructure’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 and the other reports filed by Instructure with the SEC, as well as the section entitled “Cautionary Statement Regarding Forward-Looking Statements” elsewhere in this information statement. Neither Instructure’s independent auditors, nor any other independent accountants, have compiled, examined, or performed any procedures with respect to the prospective financial information contained herein, nor have they expressed any opinion or any other form of assurance on such information or its achievability, and assume no responsibility for, and disclaim any association with, the prospective financial information.

The inclusion of this information should not be regarded as an indication that the Board, Instructure’s management, J.P. Morgan, KKR, KKR’s representatives and affiliates or any other recipient of this information considered, or now considers, the Financial Forecasts to be predictive of actual future results.

Except to the extent required by applicable federal securities laws, Instructure does not intend, and expressly disclaims any responsibility, to update or otherwise revise the Financial Forecasts to reflect circumstances existing after the date as of which such financial forecasts were prepared or to reflect the occurrence of future events or changes in general economic or industry conditions, even in the event that any of the assumptions underlying such financial forecasts are shown to be in error.

Management Forecasts

The Management Forecasts were not prepared with a view toward public disclosure and the summary thereof is included in this information statement only because the Management Forecasts were made available to representatives of J.P. Morgan by Instructure, approved by the Board and Instructure’s management for J.P. Morgan’s use in connection with J.P. Morgan’s financial analyses and opinion (as described in the sections of this information statement entitled “—Opinion of J.P. Morgan” beginning on page 36 and “—Background of the Merger” beginning on page 21) and were made available to the Board in connection with its consideration of the

42

Merger and other strategic alternatives available to Instructure and were made available to bidders, including Parent (in each case, as described in the section of this information statement entitled “—Background of the Merger” beginning on page 21 and “—Recommendation of the Board; Reasons for the Merger” beginning on page 31).

Expanded Forecasts

The Management Forecasts served as the basis for the preparation of the Expanded Forecasts described below. The Expanded Forecasts were not prepared with a view toward public disclosure and the summary thereof is included in this information statement only because the Expanded Forecasts were used by J.P. Morgan in connection with J.P. Morgan’s financial analyses and opinion, were provided to the Board and were approved by Instructure’s management for J.P. Morgan’s use in connection with their financial analyses and opinion (as described in the sections of this information statement entitled “—Opinion of J.P. Morgan” beginning on page 36 and “—Background of the Merger” beginning on page 21) and were made available to the Board in connection with its consideration of the Merger (as described in the section of this information statement entitled “—Background of the Merger” beginning on page 21 and “—Recommendation of the Board; Reasons for the Merger” beginning on page 31).

Certain of the measures included in the Financial Forecasts may be considered non-GAAP financial measures, including Adjusted EBITDA, Unlevered Free Cash Flow and Adjusted Unlevered Free Cash Flow. Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information presented in compliance with GAAP, and non-GAAP financial measures as used by Instructure may

43

not be comparable to similarly titled amounts used by other companies. Instructure has not prepared, and the Board has not considered, a reconciliation of these non-GAAP financial measures to applicable GAAP financial measures.

Financing

An investment fund affiliated with KKR has committed, pursuant to an equity commitment letter (the “Equity Commitment Letter”), to invest in Parent, at the Closing, the amount set forth therein for the purpose of funding a portion of the transactions contemplated in the Equity Commitment Letter and the Merger Agreement, on the terms and subject to the conditions set forth in the Equity Commitment Letter. Such fund has also provided a limited guarantee (the “Limited Guarantee”) in favor of Instructure, guaranteeing, subject to certain limitations set forth in the Limited Guarantee, the payment of the Parent Termination Fee in the event it becomes payable, certain indemnification obligations of Parent and Merger Sub and the reasonable out-of-pocket fees, cost and expenses incurred by Instructure in connection with any suit contemplated by, and solely to the extent reimbursable under, the Merger Agreement and the Limited Guarantee.

Additionally, in connection with entering into the Merger Agreement, Parent entered into a debt commitment letter (the “Debt Commitment Letter,” and together with the Equity Commitment Letter, the “Commitment Letters”), with the debt commitment parties signatory to the Debt Commitment Letter (each, on behalf of, or together with, one or more of its affiliates and/or managed funds, collectively, the “Debt Commitment Parties”), pursuant to which the Debt Commitment Parties have, among other things, committed to provide debt financing (the “Debt Financing”) in connection with the Merger consisting of term loan facilities and a revolving credit facility, in each case, on the terms and subject to the conditions set forth in the Debt Commitment Letter. The obligations of the Debt Commitment Parties to provide the Debt Financing under the Debt Commitment Letter are subject to satisfaction or waiver of a number of customary conditions, including the receipt of executed loan documentation, accuracy of certain representations and warranties, consummation of the transactions contemplated by the Merger Agreement and contribution of equity contemplated by the Equity Commitment Letter.

If (i) all of the conditions to the obligations of Parent and Merger Sub to consummate the Merger are satisfied or validly waived (subject to customary exceptions), (ii) Parent fails to consummate the Merger two business days after the first date on which Parent is required to consummate the Merger, (iii) Instructure irrevocably confirms to Parent in writing that all conditions of Instructure to consummate the Merger have been satisfied (subject to customary exceptions) or that it is irrevocably waiving any such unsatisfied conditions and is prepared to consummate the Merger and (iv) Parent fails to consummate the Merger within three business days after the later of (x) the date on which the Merger should have occurred pursuant to the Merger Agreement or (y) the date on which Parent receives the irrevocable confirmation of Instructure described in the foregoing clause (iii), Instructure will have the right to terminate the Merger Agreement and Parent will be obligated to pay Instructure a fee of $218,000,000 as described under “The Merger Agreement—Termination Fees and Expenses” beginning on page 74.

Interests of Our Directors and Executive Officers in the Merger

You should be aware that Instructure’s non-employee directors and executive officers have interests in the Merger that are different from, or in addition to, the interests of Instructure’s stockholders generally. The Board was aware of these interests and considered them, among other matters, in approving the Merger Agreement. These interests are described below. For purposes of the discussion below, Instructure’s executive officers are Steve Daly (Chief Executive Officer), Chris Ball (President and Chief Operating Officer), Peter Walker (Chief Financial Officer), Mitch Benson (Chief Strategy Officer), and Matthew A. Kaminer (Chief People and Legal Officer), and Instructure’s non-employee directors are Charles Goodman, Erik Akopiantz, Ossa Fisher, Lloyd Waterhouse, James Hutter, Brian Jaffee and Paul Holden Spaht, Jr. Dale Bowen resigned from his role as Chief Financial Officer of Instructure effective November 12, 2023 and provided consulting services through March 2, 2024. Mr. Bowen is not entitled to receive any type of compensation that is based on or otherwise relates to the Merger.

44

Treatment of Instructure Equity Awards and the Instructure ESPP in the Merger

Company RSUs and Company PSUs

At the Effective Time, each Vested Company RSU will automatically be cancelled and converted into the right to receive an amount in cash (without interest and subject to applicable withholding taxes) equal to the product of (i) the Per Share Price and (ii) the total number of shares of Company Common Stock subject to such Vested Company RSU as of immediately prior to the Effective Time.

At the Effective Time, each Unvested Company RSU will automatically be cancelled and replaced with a right to receive an amount in cash (without interest and subject to applicable withholding taxes), equal to the Cash Replacement Company RSU Amounts, which Cash Replacement Company RSU Amounts will, subject to the holder’s continued service with Parent or its subsidiaries (including, following the Effective Time, the surviving corporation or its subsidiaries) through the applicable vesting dates, vest and be payable at the same time as the Unvested Company RSUs for which the Cash Replacement Company RSU Amounts were exchanged would have vested and been payable pursuant to their terms (including with respect to any terms providing for acceleration of vesting pursuant to any employee plan), and will otherwise have the same terms and conditions as applied to the Unvested Company RSUs for which they were exchanged, except for terms rendered inoperative by reason of the Transactions or for such other administrative or ministerial changes as in the reasonable and good faith determination of Parent are appropriate to conform the administration of the Cash Replacement Company RSU Amounts.

At the Effective Time, each Vested Company PSU will automatically be cancelled and converted into the right to receive an amount in cash (without interest and subject to applicable withholding taxes) equal to the product of (i) the Per Share Price and (ii) the total number of shares of Company Common Stock subject to such Vested Company PSU as of immediately prior to the Effective Time.

At the Effective Time, each Unvested Company PSU will automatically be cancelled and converted into the right to receive an amount in cash (without interest and subject to applicable withholding taxes) equal to the Cash Replacement Company PSU Amounts, which Cash Replacement Company PSU Amounts will, subject to the holder’s continued service with Parent or its subsidiaries (including, following the Effective Time, the surviving corporation or its subsidiaries) through the applicable vesting dates, vest and be payable at the same time as the Unvested Company PSUs for which the Cash Replacement Company PSU Amounts were exchanged would have vested and been payable pursuant to their terms (including with respect to any terms providing for acceleration of vesting pursuant to any employee plan); provided that, to the extent any Unvested Company PSU remains outstanding and subject to such performance vesting conditions as of immediately prior to the Effective Time, the performance metrics of such Unvested Company PSU will be deemed achieved at actual levels of performance effective as of the Effective Time, to be measured with pro-ration based on the portion of the performance period that has elapsed prior to the Effective Time, in good faith by the compensation committee of the Board. All Cash Replacement Company PSU Amounts will have the same terms and conditions as applied to the Unvested Company PSU for which they were exchanged, except for terms rendered inoperative by reason of the Transactions or for such other administrative or ministerial changes as in the reasonable and good faith determination of Parent are appropriate to conform the administration of the Cash Replacement Company PSU Amounts.

As promptly as reasonably practicable after the closing date, but no later than five business days after the closing date, the holders of Vested Company RSUs and Vested Company PSUs will be paid by Instructure or the surviving corporation, through its payroll system or payroll provider, all amounts required to be paid to such holders in respect of Vested Company RSUs and Vested Company PSUs that are cancelled and converted into a cash payment, less any required withholding taxes.

In the event of a Change in Control (as defined in the Instructure Holdings, Inc. 2021 Omnibus Incentive Plan), including the Merger, any unvested portion of any Company RSU granted pursuant to the non-employee director compensation policy prior to the date of the Merger Agreement will fully vest, subject to the

45

non-employee director’s continuous service through the Effective Date. The Company RSUs held by the non-employee directors are considered to be “single-trigger” arrangements (i.e., vesting is triggered by a change in control for which payment is not conditioned upon a termination or resignation of the director). The estimated aggregate amount that would be payable to Instructure’s seven non-employee directors in settlement of their unvested Company RSUs that are outstanding as of September 2, 2024 if the Effective Time were to occur at such time is $2,050,179. The amounts in this paragraph were determined based on the assumptions set forth under “Quantification of Potential Payments and Benefits to Instructure’s Named Executive Officers in Connection with the Merger” below.

For a description of the treatment of outstanding equity awards held by Instructure’s named executive officers, see the section entitled “Instructure Employment Agreements” below and, for an estimate of the amounts that would be payable to each of Instructure’s named executive officers, see the section entitled “Quantification of Potential Payments and Benefits to Instructure’s Named Executive Officers in Connection with the Merger” below

Instructure ESPP

Pursuant to the Merger Agreement, Instructure has taken actions to ensure that (i) except for the offering period in effect as of the date of the Merger Agreement, no new offering periods will be authorized or commenced under the Instructure ESPP, (ii) no new participants will commence participation in the Instructure ESPP, (iii) no Instructure ESPP participant will be permitted to increase such participant’s payroll deduction elections or contribution rates or make separate non-payroll contributions, (iv) each purchase right outstanding under the Instructure ESPP as of July 25, 2024, will be exercised no later than three business days prior to the Effective Time, (v) each participant’s accumulated contributions will be used to purchase shares of Company Common Stock in accordance with the terms of the Instructure ESPP on the final exercise date, and (vi) the Instructure ESPP will be terminated effective as of (and subject to the occurrence of) immediately prior to the Effective Time, but subsequent to the exercise of purchase rights on the final exercise date. All shares of Company Common Stock purchased on the final exercise date under the Instructure ESPP will be cancelled at the Effective Time and converted into the right to receive the Per Share Price in accordance with the terms of the Merger Agreement. At the Effective Time, any funds credited as of such date under the Instructure ESPP that are not used to purchase shares on the final exercise date within the associated accumulated payroll withholding account for each participant under the Instructure ESPP will be refunded to the applicable participant in accordance with the terms of the Instructure ESPP.

Instructure Employment Agreements

Each of our named executive officers is party to an employment agreement with Instructure. Each of the employment agreements provides for at-will employment, which means that Instructure may terminate the executive officer’s employment at any time, with or without advance notice, and with or without cause, and the executive officer may similarly resign from employment at any time, with or without advance notice. Under the terms of the employment agreements, the Instructure executive officers are eligible to receive severance benefits upon certain terminations of employment, as described below.

Pursuant to the terms of each executive officer’s employment agreement, in the event of a termination of the executive officer’s employment by Instructure without “Cause” or by the executive officer for “Good Reason” (each, as defined in the applicable employment agreement) in either case, within three months prior to (and contingent upon the consummation of a “Change in Control” (as defined in the applicable employment agreement)) or within 12 months following the effective date of a Change in Control, including the Merger (a “CIC Termination”), the executive officer will be entitled to the following:

46

The severance payments and benefits are conditioned upon (a) the executive officer’s timely execution and non-revocation of a general release of claims in favor of Instructure, (b) the executive officer continuing to comply with standard confidentiality, non-disclosure, IP assignment, non-solicitation and non-competition obligations set forth in the executive officer’s Confidentiality and Intellectual Property Agreement and (c) the executive officer’s resignation from all positions with Instructure, any subsidiaries or affiliates, and the Board (if applicable). The severance payments and benefits set forth in the employment agreements are considered to be “double-trigger” arrangements (i.e., amounts triggered by a Change in Control for which payment is conditioned upon the executive officer’s CIC Termination).

In addition to the foregoing, the employment agreement with Mr. Daly provides for “single-trigger” vesting of all outstanding equity awards held by Mr. Daly immediately prior to a Change in Control.

For an estimate of the amounts that would be payable to each of Instructure’s named executive officers pursuant to the employment agreements, see the section entitled “Quantification of Potential Payments and Benefits to Instructure’s Named Executive Officers in Connection with the Merger” below.

Non-Employee Director Compensation

Pursuant to the terms of the Merger Agreement, Instructure may pay or grant, as applicable, to any non-employee director his or her cash and equity retainer in the ordinary course of business consistent with past practice and Instructure’s non-employee director compensation policy. Any unpaid cash retainer for the calendar quarter in which the Effective Time occurs may be paid without proration.

Other Interests

As of the date of this information statement, none of our directors or executive officers has entered into any agreement, arrangement or understanding with Parent regarding employment or service with, or compensation following the Merger to be paid by, Parent. Following the day that is 20 days after the mailing of this information statement and prior to the closing of the Merger, however, our directors or executive officers may discuss or enter into agreements, arrangements or understandings with Parent regarding employment or service with, or compensation following the Merger to be paid by, Parent. For a description of certain covenants relating to continuing employee matters set forth in the Merger Agreement, please see the section of this information statement captioned “The Merger Agreement—Continuing Employee Matters” beginning on page 66.

Instructure may engage an expert to perform calculations regarding Sections 280G and 4999 of the Code and, in consultation with Parent, in good faith, implement certain tax planning actions to the extent they may

47

reasonably mitigate any adverse tax consequences under Section 280G or 4999 of the Code that could arise in connection with the Transactions. As of the date of this information statement, the Company has not approved any specific actions to mitigate any impact of under Section 280G or 4999 of the Code.

Indemnification; Directors’ and Officers’ Insurance

Pursuant to the terms of the Merger Agreement, directors and officers of Instructure will be entitled to certain ongoing indemnification and insurance coverage, including under directors’ and officers’ liability insurance policies. For more information, see the section of this information statement entitled “The Merger Agreement—Indemnification and Insurance.”

Quantification of Potential Payments and Benefits to Instructure’s Named Executive Officers in Connection with the Merger

This section sets forth the information required by Item 402(t) of Regulation S-K regarding the compensation of each of Instructure’s named executive officers that is based on or otherwise relates to the Merger. This compensation is referred to as “golden parachute” compensation by the applicable SEC disclosure rules, and in this section we use such term to describe the merger-related compensation payable to Instructure’s named executive officers.

The table below sets forth, for purposes of this golden parachute compensation disclosure, the potential amount of payments and benefits (on a pre-tax basis) that each of Instructure’s named executive officers would receive, assuming (i) the closing had occurred on September 2, 2024 (which is the assumed closing date solely for purposes of this golden parachute compensation disclosure), (ii) each of the named executive officers experienced a CIC Termination on such date, (iii) the named executive officers’ respective base salaries and target annual bonuses remain unchanged from those that were in effect as of the date of this filing, (iv) Company RSUs held by the named executive officers that are outstanding as of the date hereof do not otherwise vest prior to the completion of the Merger, except with respect to regularly scheduled vesting dates occurring prior to the assumed closing date of September 2, 2024, (v) for purposes of determining the value of Company RSUs, the value of a share of Company Common Stock is equal to $23.60 (the Per Share Price), (vi) no named executive officer receives any additional equity grants prior to completion of the Merger, and (vii) each named executive officer has properly executed any required releases and complied with all requirements necessary in order to receive the payments and benefits described below. Some of the assumptions used in the table below are based upon estimates of information not currently available and, as a result, the actual amounts to be received by any of the individuals below may materially differ from the amounts set forth below. In addition, the calculations in the table below do not reflect any possible reductions under the Section 280G “net-better” cutback provisions included in the employment agreements described above in the section entitled “Interests of Our Directors and Executive Officers in the Merger—Instructure Employment Agreements.”

The payments described in the table below would be made pursuant to the arrangements described above in the section entitled “Interests of Our Directors and Executive Officers in the Merger.”

48

Delisting and Deregistration of Company Common Stock

If the Merger is completed, Company Common Stock will be delisted from the NYSE and deregistered under the Exchange Act, and we will no longer file periodic reports with the SEC on account of Company Common Stock.

Transaction Litigation

As of the filing of this information statement, Instructure is not aware of any complaints filed or litigation pending related to the Merger.

49

Material United States Federal Income Tax Consequences of the Merger

The following is a summary of the material United States federal income tax consequences of the Merger generally applicable to holders of Company Common Stock who exchange their shares of Company Common Stock for cash pursuant to the Merger. The summary is based on the United States Internal Revenue Code of 1986, as amended (the “Code”), applicable United States Treasury Regulations issued thereunder, judicial authority and administrative rulings and pronouncements, all of which are subject to change, possibly with retroactive effect. Any such change, which may or may not be retroactive, could alter the tax consequences described herein. The discussion applies only to holders whose shares of Company Common Stock are held as capital assets (generally, property held for investment), and does not address the tax consequences that may be relevant to holders of Company Common Stock that are subject to special tax rules, such as insurance companies, United States expatriates, controlled foreign corporations, passive foreign investment companies, holders subject to the alternative minimum tax, tax-exempt organizations, broker-dealers, banks, financial institutions, regulated investment companies, real estate investment trusts, cooperatives, traders in securities that elect to mark to market, United States Holders whose functional currency is not the United States dollar, holders who hold Company Common Stock through pass-through entities for United States federal income tax purposes or as part of a hedge, straddle or conversion transaction, holders deemed to sell Company Common Stock under the constructive sale provisions of the Code, holders who exercise appraisal rights, or holders who acquired Company Common Stock pursuant to the exercise of employee stock options or otherwise as compensation. This summary does not address (i) any aspect of state, local or non-United States taxation, and does not address any United States federal taxation other than income taxation, (ii) any tax consequences to holders of any interests in Instructure other than Company Common Stock, including Company RSUs or Company PSUs, (iii) any tax consequences of any other transaction occurring in connection with the Merger or (iv) the Medicare tax on net investment income.

For purposes of this information statement, a “United States Holder” means a beneficial owner of Company Common Stock that is (as determined for United States federal income tax purposes):

The term “Non-United States Holder” refers to any beneficial owner of Company Common Stock, other than a partnership or other entity or arrangement treated as a partnership for United States federal income tax purposes, that is not a United States Holder.

If a partnership or other entity or arrangement treated as a partnership for United States federal income tax purposes is a holder of Company Common Stock, the United States federal income tax treatment of a partner in that partnership will generally depend upon the status of the partner and the activities of the partnership. Partners of a holder of Company Common Stock should consult their own tax advisors as to the particular United States federal income tax consequences of the Merger to them.

The United States federal income tax consequences set forth below are included for general informational purposes only and are based upon current law as of the date hereof. Because individual circumstances may differ, each holder of Company Common Stock should consult such holder’s own tax

50

advisor to determine the applicability of the rules discussed below to such holder and the particular tax effects of the Merger, including the application and effect of United States federal, state, local and non-United States tax laws.

United States Holders. The receipt of the Merger consideration by a United States Holder in exchange for shares of Company Common Stock pursuant to the Merger will be a taxable transaction for United States federal income tax purposes (and also may be a taxable transaction under applicable state, local, non-United States and other income tax laws). In general, for United States federal income tax purposes, a United States Holder who receives the Merger consideration will recognize gain or loss in an amount equal to the difference between (x) the amount of cash the United States Holder receives (determined before deduction of any applicable withholding taxes) and (y) such United States Holder’s adjusted tax basis of the surrendered shares of Company Common Stock. A United States Holder’s adjusted tax basis generally will equal the price the United States Holder paid for such shares, and if applicable, will have been reduced by return of capital distributions. Gain or loss will be calculated separately for each block of Company Common Stock (generally shares acquired at the same cost in a single transaction) converted in the Merger. Such gain or loss generally will be capital gain or loss, and will be long-term capital gain or loss if Company Common Stock has been held for more than one year as of the Effective Time. Long-term capital gains of non-corporate United States Holders may be eligible for reduced rates of taxation. The deductibility of capital losses is limited.

Non-United States Holders. Subject to the discussion below regarding backup withholding, a Non-United States Holder that receives cash for shares of Company Common Stock pursuant to the Merger generally will not be subject to United States federal income tax on any gain realized on the disposition, unless (i) such holder is an individual who is present in the United States for 183 or more days during the taxable year of the Merger and certain other conditions are met, (ii) the gain is effectively connected with the conduct of a trade or business in the United States by the Non-United States Holder (and, in the case of certain income tax treaties, is attributable to a permanent establishment or fixed base within the United States) or (iii) such holder owned, directly or under certain constructive ownership rules of the Code, more than 5% of Company Common Stock at any time during the five-year period preceding the Merger, and Instructure is or has been a “United States real property holding corporation” for United States federal income tax purposes at any time during the shorter of the five-year period preceding the Merger or the period that the Non-United States Holder held Company Common Stock. Instructure believes it is not and has not been a “United States real property holding corporation” for United States federal income tax purposes at any time during the five-year period preceding the Merger.

If you are a Non-United States Holder who is an individual and has been present in the United States for 183 or more days during the taxable year of the Merger and certain other conditions are satisfied, you will be subject to tax at a rate of 30% (or such lower rate as may be specified in an applicable income tax treaty) on any gain realized, which generally may be offset by certain United States source capital losses.

If you are a Non-United States Holder and your gain is effectively connected with the conduct of a United States trade or business by you (and, in the case of certain income tax treaties, is attributable to a permanent establishment or fixed base within the United States), you will be subject to United States federal income tax on any gain realized on a net basis in the same manner as a United States Holder. Non-United States Holders that are corporations may also be subject to a branch profits tax on such effectively connected income at a rate of 30% (or such lower rate as may be specified in an applicable income tax treaty), subject to adjustments.

Information Reporting and Backup Withholding. Cash consideration received by a United States Holder or a Non-United States Holder in the Merger may be subject to information reporting and backup withholding. To avoid backup withholding, a United States Holder that does not otherwise establish an exemption should complete and return to the applicable paying agent an Internal Revenue Service (“IRS”) Form W-9, certifying that such United States Holder is a United States person, that the taxpayer identification number provided is correct and that such United States Holder is not subject to backup withholding. A Non-United States Holder generally may establish an exemption from backup withholding by certifying its status as a non-United States

51

person under penalties of perjury on an IRS Form W-8BEN or other applicable IRS Form W-8. Backup withholding is not an additional tax. Amounts so withheld can be credited against such holder’s federal income tax liability and may entitle such holder to a refund, provided that the required information is timely furnished to the IRS.

United States Holders and Non-United States Holders should consult their tax advisors regarding the application of United States federal income tax laws and non-United States tax laws, including information reporting and backup withholding, to their particular situations.

Additional Withholding Requirements under the Foreign Account Tax Compliance Act. Sections 1471 through 1474 of the Code, and the United States Treasury Regulations and administrative guidance issued thereunder (collectively, “FATCA”), impose a United States federal withholding tax of 30% on certain payments made to a “foreign financial institution” (as specially defined under these rules) unless such institution enters into an agreement with the United States government to withhold on certain payments and to collect and provide to the United States tax authorities substantial information regarding certain United States account holders of such institution (which include certain equity and debt holders of such institution, as well as certain account holders that are foreign entities with United States owners) or an exemption applies. FATCA also generally imposes a United States federal withholding tax of 30% on certain payments made to a non-financial foreign entity unless such entity provides the withholding agent a certification identifying certain direct and indirect United States owners of the entity or an exemption applies. An intergovernmental agreement between the United States and an applicable foreign country may modify these requirements. Under certain circumstances, a Non-United States Holder might be eligible for refunds or credits of such taxes.

The United States Treasury Department has released proposed regulations which, if finalized in their present form, would eliminate the FATCA withholding applicable to the gross proceeds of a sale or other disposition of our common stock. In its preamble to such proposed regulations, the United States Treasury Department stated that taxpayers may generally rely on the proposed regulations until final regulations are issued.

Holders of Company Common Stock should consult with their tax advisors regarding the possible implications of FATCA on the disposition of Company Common Stock pursuant to the Merger.

Regulatory Approvals

Under the Merger Agreement, we and the other parties to the Merger Agreement have agreed to use our respective reasonable best efforts to complete the transactions contemplated by the Merger Agreement, including to obtain all necessary governmental approvals as promptly as practicable. In addition, each of Instructure and Parent has agreed to (i) cooperate and coordinate (and cause its respective ultimate parent entity to cooperate and coordinate) with each other in the making of specified regulatory filings; (ii) supply the other (or cause the other to be supplied) with any information that may be required in order to make such filings; (iii) supply (or cause to be supplied) any additional information that may be required or requested by the FTC, the Department of Justice or the governmental authorities of any other applicable jurisdiction in which any such filing is made; and (iv) use reasonable best efforts to take all actions necessary, proper or advisable to (1) cause the expiration or termination of the applicable waiting periods pursuant to any antitrust laws or foreign investment laws applicable to the Merger Agreement or the Merger; and (2) obtain all clearances, consents, approvals, waivers, actions, non-actions and other authorizations pursuant to any antitrust laws or foreign investment laws applicable to the Merger Agreement or the Merger, in each case as promptly as practicable.

If and to the extent necessary to obtain the necessary governmental approvals pursuant to applicable antitrust laws applicable to the Merger and to avoid or eliminate each and every impediment under any antitrust laws applicable to the Merger as promptly as practicable, each of Parent and Merger Sub have agreed to use reasonable best efforts to offer, negotiate, commit to and effect, by consent decree, hold separate order or otherwise, and use reasonable best efforts to take all actions necessary to avoid or eliminate any impediment and

52

to obtain all clearances, consents, approvals, waivers, actions, waiting period expirations or terminations, non-actions or other authorizations under the HSR Act and any other antitrust laws, including (i) the sale, divestiture, transfer, license, disposition, or hold separate (through the establishment of a trust or otherwise), of any and all of the capital stock or other equity or voting interest, assets (whether tangible or intangible), rights, properties, products or businesses of Parent and Merger Sub and of Instructure and its subsidiaries; (ii) the termination, modification, or assignment of existing relationships, joint ventures, contracts, or obligations of Instructure and its subsidiaries; (iii) the modification of any course of conduct regarding future operations of Instructure and its subsidiaries; and (iv) any other restrictions on the activities of Parent and Merger Sub and of Instructure and its subsidiaries, including the freedom of action of Instructure and its subsidiaries with respect to, or their ability to retain, one or more of their respective operations, divisions, businesses, product lines, customers, assets or rights or interests, or their freedom of action with respect to the assets, properties, or businesses to be acquired pursuant to the Merger Agreement, in each case, so as to allow the consummation of the Merger as soon as practicable; provided, that Parent and Merger Sub shall not be obligated to take any action with respect to KKR and its affiliates and investment funds or investment vehicles affiliated with, or managed or advised by, KKR or any portfolio company (as such term is commonly understood in the private equity industry), any interest therein, or any investment of KKR, other than with respect to Parent, Merger Sub, and Instructure and its subsidiaries, and that Instructure and its subsidiaries or affiliates shall not be required to enter into any agreement or consent decree with the DOJ, FTC or any other governmental authority that is not conditioned on the Closing.

Under the HSR Act and related rules, certain transactions, including the Merger, may not be completed until notifications have been given and information furnished to the Antitrust Division and the FTC and all statutory waiting period requirements have been satisfied by the applicable agencies. On August 8, 2024, both Instructure and Parent filed their respective notification and report forms under the HSR Act, which triggered the start of the HSR Act waiting period. The waiting period under the HSR Act will expire at 11:59 p.m. EST on September 9, 2024.

Under other applicable foreign antitrust laws and foreign investment laws, certain transactions, including the Merger, may not be completed until any requisite consent, non-action or expiration of any applicable waiting period is obtained.

As of the date of this information statement, the parties have not received all of the consents (including non-action or expiration of any applicable waiting period) under antitrust laws and foreign investment laws required by the Merger Agreement.

At any time before or after the Effective Time of the Merger, the Antitrust Division or the FTC, or the governmental authorities of any other applicable jurisdiction in which a filing is required under applicable foreign antitrust laws, could take action under the antitrust laws, including seeking to prevent the Merger, to rescind the Merger or to conditionally approve the Merger upon the divestiture of assets of Instructure or Parent or subject to regulatory conditions or other remedies. In addition, U.S. state attorneys general could take action under the antitrust laws as they deem necessary or desirable in the public interest, including, without limitation, seeking to enjoin the completion of the Merger or permitting completion subject to regulatory conditions. Private parties may also seek to take legal action under the antitrust laws under some circumstances. There can be no assurance that a challenge to the Merger on antitrust grounds will not be made or, if such a challenge is made, that it would not be successful.

53

THE MERGER AGREEMENT

This section describes the material terms and conditions of the Merger Agreement. The description in this section and elsewhere in this information statement is qualified in its entirety by reference to the complete text of the Merger Agreement, a copy of which is attached as Annex A and is incorporated by reference into this information statement. This summary does not purport to be complete and may not contain all of the information about the Merger Agreement that is important to you. We encourage you to read the Merger Agreement carefully and in its entirety. This section is not intended to provide you with factual information about Instructure. Such information can be found elsewhere in this information statement and in the public filings Instructure makes with the SEC, which may be obtained by following the instructions set forth in the section entitled, “Where You Can Find More Information,” beginning on page 89.

Explanatory Note Regarding the Merger Agreement

The Merger Agreement has been included to provide you with information regarding its terms. It is not intended to provide any other factual information about Instructure, Parent, Merger Sub or any of their respective subsidiaries or affiliates. The representations, warranties and covenants contained in the Merger Agreement were made by the parties thereto only for purposes of that agreement and as of specific dates; were made solely for the benefit of the parties to the Merger Agreement; may be subject to limitations agreed upon by the contracting parties, including being qualified by confidential disclosures exchanged between the parties in connection with the execution of the Merger Agreement (such disclosures include information that has been included in Instructure’s public disclosures, as well as additional nonpublic information); may have been made for the purposes of allocating contractual risk between the parties to the Merger Agreement instead of establishing these matters as facts; and may be subject to standards of materiality applicable to the contracting parties that differ from those applicable to you. You should not rely on the representations, warranties and covenants or any descriptions thereof as characterizations of the actual state of facts or condition of Instructure, Parent, Merger Sub or any of their respective subsidiaries or affiliates. Additionally, the representations, warranties, covenants, conditions and other terms of the Merger Agreement may be subject to subsequent waiver or modification. Moreover, information concerning the subject matter of the representations, warranties and covenants may change after the date of the Merger Agreement, which subsequent information may or may not be fully reflected in Instructure’s public disclosures.

Form of Merger

Upon the terms and subject to the conditions of the Merger Agreement, and in accordance with the DGCL, at the Effective Time, Merger Sub will be merged with and into Instructure, whereupon the separate corporate existence of Merger Sub will cease, and Instructure will continue as the surviving corporation and a wholly-owned subsidiary of Parent.

Consummation and Effectiveness of the Merger

The Merger will become effective at such time as the certificate of merger has been duly filed with the Secretary of State of the State of Delaware, or at such other time as Parent, Merger Sub and Instructure agree and specify in the certificate of merger. The consummation of the Merger will take place at a closing to occur at 9:00 a.m., New York City time, on a date to be agreed upon by Parent, Merger Sub and Instructure, which date will be no later than the third business day after the satisfaction or waiver (to the extent permitted by the Merger Agreement) of the last to be satisfied or waived of the conditions to the consummation of the Merger set forth in the Merger Agreement (other than those conditions that by their terms are to be satisfied at the closing, but subject to the satisfaction or waiver (to the extent permitted by the Merger Agreement) of such conditions), unless another time or date is agreed to in writing by Parent, Merger Sub and Instructure; provided that, the closing date shall not occur prior to September 25, 2024 without the written consent of Parent.

54

Consideration to be Received in the Merger

Subject to the terms and conditions of the Merger Agreement, at the Effective Time, (i) each share of common stock, par value $0.01 per share of Merger Sub that is issued and outstanding as of immediately prior to the Effective Time will automatically be cancelled and converted into one validly issued, fully paid and nonassessable share of common stock of the surviving corporation, (ii) each share of Company Common Stock that is issued and outstanding as of immediately prior to the Effective Time other than Owned Company Shares or Dissenting Company Shares will be automatically cancelled, extinguished and converted into the right to receive the Per Share Price (subject to applicable withholding taxes); and (iii) each share of the Owned Company Shares will automatically be cancelled and extinguished without any conversion thereof or consideration paid therefor.

Treatment of Instructure Equity Awards and Instructure ESPP in the Merger

At the Effective Time, each Vested Company RSU will automatically be cancelled and converted into the right to receive an amount in cash (without interest and subject to applicable withholding taxes) equal to the product of (i) the Per Share Price and (ii) the total number of shares of Company Common Stock subject to such Vested Company RSU as of immediately prior to the Effective Time.

At the Effective Time, each Unvested Company RSU will automatically be cancelled and replaced with a right to receive an amount in cash (without interest and subject to applicable withholding taxes) equal to the Cash Replacement Company RSU Amounts, which Cash Replacement Company RSU Amounts will, subject to the holder’s continued service with Parent or its subsidiaries (including, following the Effective Time, the surviving corporation or its subsidiaries) through the applicable vesting dates, vest and be payable at the same time as the Unvested Company RSUs for which the Cash Replacement Company RSU Amounts were exchanged would have vested and been payable pursuant to their terms (including with respect to any terms providing for acceleration of vesting pursuant to any employee plan), and will otherwise have the same terms and conditions as applied to the Unvested Company RSUs for which they were exchanged, except for terms rendered inoperative by reason of the Transactions or for such other administrative or ministerial changes as in the reasonable and good faith determination of Parent are appropriate to conform the administration of the Cash Replacement Company RSU Amounts.

At the Effective Time, each Vested Company PSU will automatically be cancelled and converted into the right to receive an amount in cash (without interest and subject to applicable withholding taxes) equal to the product of (i) the Per Share Price and (ii) the total number of shares of Company Common Stock subject to such Vested Company PSU as of immediately prior to the Effective Time.

At the Effective Time, each Unvested Company PSU will automatically be cancelled and converted into the right to receive an amount in cash (without interest and subject to applicable withholding taxes) equal to the Cash Replacement Company PSU Amounts, which Cash Replacement Company PSU Amounts will, subject to the holder’s continued service with Parent or its subsidiaries (including, following the Effective Time, the surviving corporation or its subsidiaries) through the applicable vesting dates, vest and be payable at the same time as the Unvested Company PSUs for which the Cash Replacement Company PSU Amounts were exchanged would have vested and been payable pursuant to their terms (including with respect to any terms providing for acceleration of vesting pursuant to any employee plan); provided that, to the extent any Unvested Company PSU remains outstanding and subject to such performance vesting conditions as of immediately prior to the Effective Time, the performance metrics of such Unvested Company PSU will be deemed achieved at actual levels of performance effective as of the Effective Time, to be measured with pro-ration based on the portion of the performance period that has elapsed prior to the Effective Time, in good faith by the compensation committee of the Board. All Cash Replacement Company PSU Amounts will have the same terms and conditions (including with respect to time-based vesting) as applied to any Unvested Company PSU for which they were exchanged, except for terms rendered inoperative by reason of the Transactions or for such other administrative or ministerial

55

changes as, in the reasonable and good faith determination of Parent are appropriate to conform the administration of the Cash Replacement Company PSU Amounts.

As promptly as reasonably practicable after the closing date, but no later than five business days after the closing date, the holders of Vested Company RSUs and Vested Company PSUs will be paid by Instructure or the surviving corporation, through its payroll system or payroll provider, all amounts required to be paid to such holders in respect of Vested Company RSUs and Vested Company PSUs that are cancelled and converted into a cash payment, less any applicable withholding taxes.

Pursuant to the Merger Agreement, Instructure has taken actions to ensure that (i) except for the offering period in effect as of the date of the Merger Agreement, no new offering periods will be authorized or commenced under the Instructure ESPP, (ii) no new participants will commence participation in the Instructure ESPP, (iii) no Instructure ESPP participant will be permitted to increase such participant’s payroll deduction elections or contribution rates or make separate non-payroll contributions, (iv) each purchase right outstanding under the Instructure ESPP as of July 25, 2024 will be exercised no later than three business days prior to the Effective Time, (v) each participant’s accumulated contributions will be used to purchase shares of Company Common Stock in accordance with the terms of the Instructure ESPP on the final exercise date, and (vi) the Instructure ESPP will be terminated effective as of (and subject to the occurrence of) immediately prior to the Effective Time, but subsequent to the exercise of purchase rights on the final exercise date. All shares of Company Common Stock purchased on the final exercise date under the Instructure ESPP will be cancelled at the Effective Time and converted into the right to receive the Per Share Price in accordance with the terms of the Merger Agreement. At the Effective Time, any funds credited as of such date under the Instructure ESPP that are not used to purchase shares on the final exercise date within the associated accumulated payroll withholding account for each participant under the Instructure ESPP will be refunded to the applicable participant in accordance with the terms of the Instructure ESPP.

Appraisal Shares

Dissenting Company Shares will not be converted into the right to receive the Per Share Price, and instead, holders of such Dissenting Company Shares will only be entitled to receive payment of the fair value of such Dissenting Company Shares in accordance with the provisions of Section 262 of the DGCL, unless and until any such holder fails to perfect, waives or effectively withdraws or otherwise loses their rights to appraisal and payment under the DGCL. However, if, after the Effective Time, any such holder fails to perfect, waive or effectively withdraws or otherwise loses the right to appraisal under Section 262 of the DGCL or a court of competent jurisdiction determines that such holder is not entitled to the relief provided by Section 262 of the DGCL, such Dissenting Company Shares will be deemed to have been converted into, as of the Effective Time, the right to receive the Per Share Price. Prior to the Effective Time, Instructure will provide (i) prompt (and in any event within two business days) notice to Parent of any demands received by Instructure for appraisal of shares of Company Common Stock, withdrawals of such demands and any other instruments served pursuant to the DGCL and received by Instructure in respect of Dissenting Company Shares and (ii) the opportunity to review and consult with Instructure regarding any negotiations and proceedings with respect to such demands and the Company will consider in good faith Parent’s views and comments with respect thereto. Except with the prior written consent of Parent, Instructure will not make any payment or deliver any consideration with respect to any demands for appraisal or settle or offer to settle any such demands, waive any failure to timely deliver a demand for appraisal pursuant to, or otherwise comply with, Section 262 of the DGCL, or agree to do any of the foregoing. Prior to the Effective Time, Parent will not, except with the prior written consent of Instructure, require Instructure to make any payment with respect to any demands for appraisal or offer to settle or settle any such demands.

Procedures for Receiving Merger Consideration

Prior to the Closing, Parent will select a nationally recognized bank or trust company reasonably acceptable to Instructure to act as the paying agent for the payment of the aggregate consideration to which holders of shares

56

of Company Common Stock are entitled pursuant to the Merger Agreement and at or prior to the Closing, Parent will deposit or cause to be deposited with the paying agent for payment to the holders of shares of Company Common Stock (other than with respect to Owned Company Shares or Dissenting Company Shares), an amount in cash equal to the aggregate consideration to which holders of shares of Company Common Stock are entitled pursuant to the Merger Agreement.

Promptly (and in any event no later than three business days) after the Effective Time, Parent and the surviving corporation will use reasonable best efforts to cause the paying agent to mail to each holder of record as of immediately prior to the Effective Time (other than Owned Company Shares and Dissenting Company Shares, as applicable) of any Certificates (i) a letter of transmittal in customary form (which will specify that delivery will be effected, and risk of loss and title to the Certificates will pass, only upon delivery of the Certificates to the paying agent) and (ii) instructions for effecting the surrender of the Certificates in exchange for the Per Share Price payable with respect to the shares of Company Common Stock formerly represented by the Certificates. Upon surrender of Certificates for cancellation to the paying agent, together with such letter of transmittal, duly completed and validly executed in accordance with the instructions thereto, the holders of such Certificates will be entitled to receive in exchange therefor an amount in cash (subject to applicable withholding taxes) equal to the product obtained by multiplying (x) the aggregate number of shares of Company Common Stock represented by such Certificates by (y) the Per Share Price, and the Certificates so surrendered will be cancelled. With respect to record holders of Uncertificated Shares, in lieu of the delivery of a Certificate or an executed letter of transmittal to the paying agent, upon the paying agent’s receipt of an “agent’s message” (or such other evidence, if any, of transfer as the paying agent may reasonably request), the holder of such Uncertificated Shares will be entitled to receive in exchange thereof an amount in cash (subject to applicable withholding taxes) equal to the product obtained by multiplying (1) the aggregate number of shares of Company Common Stock represented by such holder’s transferred Uncertificated Shares by (2) the Per Share Price, and the transferred Uncertificated Shares will be cancelled.

No interest will be paid or accrue on the cash payable to any holder of a Certificate or Uncertificated Share.

Each of the surviving corporation, Parent, the paying agent and their respective affiliates and agents will be entitled to deduct and withhold from any cash amounts otherwise payable to any person pursuant to the Merger Agreement such amounts as may be required to be deducted and withheld under applicable law with respect to taxes. Any amounts so deducted or withheld and paid over to the appropriate taxing authority will be treated for all purposes as having been paid to the person in respect of which such deduction or withholding was made.

Certificate of Incorporation; Bylaws

At the Effective Time, by virtue of the Merger, (a) the certificate of incorporation of Instructure as in effect immediately prior to the Effective Time will be amended and restated in its entirety to be read as set forth in the applicable exhibit attached to the Merger Agreement, and as so amended and restated, will be the certificate of incorporation of the surviving corporation, until thereafter amended as provided by the DGCL and such certificate of incorporation (b) the bylaws of Merger Sub as in effect immediately prior to the Effective Time will become the bylaws of the surviving corporation, except that all references to Merger Sub shall be automatically amended and become references to the surviving corporation, until thereafter amended as provided by the DGCL, the certificate of incorporation and such bylaws.

Representations and Warranties

The Merger Agreement contains customary representations and warranties of Parent, Merger Sub and Instructure, including representations and warranties relating to, among other things:

57

In addition, the Merger Agreement contains the following customary representations and warranties of Instructure relating to, among other things:

The Merger Agreement also contains the following customary representations and warranties of Parent and Merger Sub:

58

Certain of the representations and warranties in the Merger Agreement are qualified as to “materiality” or “Company Material Adverse Effect” or words of similar import. The Merger Agreement provides that a Company Material Adverse Effect means any change, event, effect, occurrence or development that, individually or in the aggregate, has or would reasonably be expected to have, a material adverse effect on the business, financial condition, assets, liabilities or results of operations of Instructure and its subsidiaries, taken as a whole; provided, that none of the following, and no conditions, changes, events, effects, occurrences or developments arising out of, relating to or resulting from the following (by itself or when aggregated), will be deemed to constitute a Company Material Adverse Effect or will be taken into account when determining whether a Company Material Adverse Effect has occurred (subject to the limitations below):

59

Conduct of Business by Instructure Prior to Consummation of the Merger

Except (a) as expressly contemplated by the Merger Agreement, (b) for certain matters set forth on the confidential disclosure schedules, (c) as required by applicable law or (d) as approved by Parent in writing (which approval shall not to be unreasonably withheld, conditioned or delayed) during the period from the date of the Merger Agreement until the earlier to occur of the valid termination of the Merger Agreement and the

60

Effective Time, Instructure will and will cause each of its subsidiaries to use its commercially reasonable efforts to (i) conduct its business in all material respects in the ordinary course of business and (ii) preserve intact in all material respects its business organization, properties, rights and assets and relationships with and goodwill with its key employees, material customers, suppliers, landlords, governmental authorities and other Persons having material business relationships with Instructure or its subsidiaries.

In addition, except as set forth on the confidential disclosure schedules, as expressly contemplated by the Merger Agreement, required by applicable law, or as approved by Parent in writing (such consent not to be unreasonably withheld, conditioned or delayed), from the date of the Merger Agreement to the earlier to occur of the termination of the Merger Agreement and the Effective Time, Instructure shall not, and shall not permit any of its subsidiaries to:

61

62

Regulatory Filings; Efforts

Each party to the Merger Agreement will use its reasonable best efforts to (i) take (or cause to be taken) all actions; (ii) do (or cause to be done) all things; and (iii) assist and cooperate with the other Parties in doing (or causing to be done) all things, in each case as are necessary, proper or advisable pursuant to applicable law or otherwise to consummate and make effective, as promptly as reasonably practicable, the Merger and the transactions contemplated by the Merger Agreement, including by using reasonable best efforts to (A) cause the conditions precedent to closing in the Merger Agreement that are within such party’s control to be satisfied and (B) (I) obtain all consents, waivers, approvals, orders and authorizations from governmental authorities; and (II) make all registrations, declarations and filings with governmental authorities, in each case that are necessary or advisable to consummate the transactions contemplated by the Merger Agreement.

Each party will, (i) within ten business days of entering into the Merger Agreement file with the FTC and the Antitrust Division of the DOJ a Notification and Report Form relating to the Merger Agreement and the transactions contemplated by the Merger Agreement as required by the HSR Act (unless the applicable rules governing the form and information required in such filings under the HSR Act have materially changed and are

63

in effect at the time such a filing would have to be made, in which case it shall be made as promptly as reasonably practicable); and (ii) as soon as reasonably practicable after entering into the Merger Agreement, file any such notification filings, forms and submissions, including any draft notifications in jurisdictions requiring pre-notification with any governmental authority as are required by other applicable antitrust laws or foreign investment laws in connection with the Merger. In relation to this, each party will make (or cause to be made), as promptly as reasonably practicable and after consultation with the other parties, an appropriate response to a request for any additional information or documentary material from any governmental authority with respect to the Merger pursuant to the HSR Act or any other antitrust laws or foreign investment laws applicable to the Merger.

If and to the extent necessary to obtain clearances, consents, approvals, waivers, actions, waiting period expirations or terminations, non-actions or other authorizations pursuant to the HSR Act or any other antitrust laws applicable to the Merger, and to avoid or eliminate each and every impediment under any antitrust law applicable to the Merger as promptly as practicable, each of Parent and Merger Sub shall use reasonable best efforts to offer, negotiate, commit to and effect, by consent decree, hold separate order or otherwise, and use reasonable best efforts to take all actions necessary to avoid or eliminate each and every impediment and obtain all clearances, consents, approvals, waivers, actions, waiting period expirations or terminations, non-actions or other authorizations under the HSR Act and any other antitrust laws including (i) the sale, divestiture, transfer, license, disposition, or hold separate (through the establishment of a trust or otherwise), of any and all of the capital stock or other equity or voting interest, assets (whether tangible or intangible), rights, properties, products or businesses of Parent and Merger Sub and of Instructure and its subsidiaries; (ii) the termination, modification, or assignment of existing relationships, joint ventures, contracts, or obligations of Instructure and its subsidiaries; (iii) the modification of any course of conduct regarding future operations of Instructure and its subsidiaries; and (iv) any other restrictions on the activities of Parent and Merger Sub and of Instructure and its subsidiaries, including the freedom of action of Instructure and its subsidiaries with respect to, or their ability to retain, one or more of their respective operations, divisions, businesses, product lines, customers, assets or rights or interests, or their freedom of action with respect to the assets, properties, or businesses to be acquired pursuant to the Merger Agreement; in each case, so as to allow the consummation of the Merger as soon as practicable. Parent shall use reasonable best efforts to oppose any request for, the entry of, and seek to have vacated or terminated, any order, judgment, decree, injunction or ruling of any governmental authority that could restrain, prevent or delay any required consents, clearances, approvals, waivers, actions, waiting period expirations or terminations, non-actions or other authorizations applicable to the Merger, including by defending through litigation, any action asserted by any person in any court or before any governmental authority and by exhausting all avenues of appeal, including appealing properly any adverse decision or order by any governmental authority; provided, that neither Parent nor Merger Sub shall be obligated to take any action, with respect to KKR & Co. and KKR (collectively, the “KKR Entities”) and their respective affiliates and any investment funds or investment vehicles affiliated with, or managed or advised by, the KKR Entities or any portfolio company (as such term is commonly understood in the private equity industry), any interest therein, or any investment of the KKR Entities, other than with respect to Parent, Merger Sub, and Instructure and its subsidiaries.

Notwithstanding the foregoing, nothing in the Merger Agreement shall require Instructure and its subsidiaries or affiliates to enter into any agreement or consent decree with the DOJ, FTC or any other governmental authority that is not conditioned on the closing.

Furthermore, Parent and Merger Sub will not, and will cause the investment fund affiliated with KKR that provided the limited guarantee not to, enter into, agree to enter into, or consummate any contracts or arrangements for an acquisition (by stock purchase, merger, consolidation, purchase of assets, license or otherwise) of any ownership interest, equity interests, assets or rights in or of any person, or take any other actions that would reasonably be expected to, individually or in the aggregate, (A) prevent, materially delay or materially impede the obtaining of, or adversely affect in any material respect the ability of Parent to procure, any clearances, approvals, waivers, actions, non-actions, authorizations, consents, orders or declarations of any governmental authority or the expiration or termination of any applicable waiting period necessary to

64

consummate the transactions contemplated in the Merger Agreement, including the Merger; or (B) materially increase the risk of any governmental authority entering an order, ruling, judgment or injunction prohibiting the consummation of the transactions contemplated in the Merger Agreement, including the Merger. Prior to the closing, Parent and Merger Sub shall not take any action that will trigger a mandatory filing obligation pursuant to Section 721 of the Defense Production Act of 1950, including all implementing regulations thereof.

Written Consent

Per the terms of the Merger Agreement, the Written Consent was delivered to Instructure on July 25, 2024 shortly after the execution of the Merger Agreement. Instructure provided a copy of the Written Consent to Parent on July 25, 2024, shortly after its receipt of the Written Consent.

No Solicitation or Negotiation

The Merger Agreement provides that during the period beginning at the time of the execution of the Merger Agreement and continuing until the earlier to occur of the valid termination of the Merger Agreement pursuant to its terms and the Effective Time (the “Interim Period”), Instructure will, and will cause its subsidiaries and their respective directors and officers to, and will direct and use its reasonable best efforts to cause its other representatives to, (w) immediately cease and cause to be terminated any solicitations, discussions, communications or negotiations with any person and its representatives that would be prohibited by the terms of the Merger Agreement, (x) immediately cease providing any information with respect to Instructure or any Acquisition Proposal to any such person or its representatives, (y) immediately terminate all access granted to any such person and its representatives to any physical or electronic data room (or any other diligence access) and (z) promptly request that any such person and its representatives return to Instructure or destroy any non-public information concerning Instructure or its subsidiaries that was previously furnished or made available to such person or any of its representatives by or on behalf of Instructure in accordance with the terms of any confidentiality agreement in place with such person, in each case, other than Parent, Merger Sub and their representatives. During the Interim Period, Instructure and its subsidiaries will not, and will cause its subsidiaries, and its and their respective officers and directors not to, and will direct and use its reasonable best efforts to cause any of their other respective representatives to not, directly or indirectly:

65

During the Interim Period, Instructure will not be required to enforce, and will be permitted to waive, any provision of any standstill or confidentiality agreement that prohibits or purports to prohibit a proposal being made to the Board (or any committee thereof).

The Merger Agreement provides that the term “Acquisition Proposal” means any offer or proposal (other than an offer or proposal by Parent or Merger Sub) relating to an Acquisition Transaction.

Furthermore, the term “Acquisition Transaction” means any transaction or series of related transactions (other than the Merger) involving:

For the avoidance of doubt, the Merger and the other transactions contemplated by the Merger Agreement will not be deemed an Acquisition Proposal.

Continuing Employee Matters

The Merger Agreement provides that, for a period of 12 months following the Effective Time, the surviving corporation and its subsidiaries will maintain for the benefit of each employee of Instructure or its subsidiaries who remains in the employment of the surviving corporation and its subsidiaries (each, a “Continuing Employee”) (i) base salary or wage rate and target short-term cash incentive opportunities (including bonus and commission opportunities) that are, in each case, no less than those in effect for such Continuing Employee immediately before the Effective Time, (ii) severance and termination benefits that are no less favorable than those applicable to such Continuing Employee immediately before the Effective Time, and (iii) other employee benefit plans, programs, policies, agreements or arrangements of the surviving corporation or any of its subsidiaries (excluding retention, change-in-control compensation, equity or equity-based plans and arrangements and other similar long-term compensation, nonqualified deferred compensation, retiree medical or retiree welfare arrangements and defined benefit pension benefits) at levels that are substantially similar in the aggregate to those in effect for (or available to) such Continuing Employees under the employee plans as of the Effective Time.

With respect to each benefit or compensation plan, program, policy, arrangement or agreement that is made available to any Continuing Employee at or after the Effective Time (each, a “New Plan”), the surviving corporation and its subsidiaries will cause to be granted to such Continuing Employee credit for all service with Instructure and its subsidiaries prior to the Effective Time for purposes of eligibility to participate, vesting and entitlement to benefits where length of service is relevant (including for purposes of vacation accrual and severance entitlement or termination pay), subject to certain exceptions. In addition, Parent will cause the

66

surviving corporation and its subsidiaries to (i) use commercially reasonable efforts to cause each Continuing Employee to be immediately eligible to participate, without any waiting period, in any and all New Plans to the extent that coverage pursuant to any such New Plan replaces coverage pursuant to a corresponding employee plan (such plans, the “Old Plans”); (ii) for purposes of each New Plan providing life insurance, medical, dental, pharmaceutical, vision or disability benefits use commercially reasonable efforts to cause all waiting periods, pre-existing condition exclusions, evidence of insurability requirements and actively-at-work or similar requirements of such New Plan to be waived for the Continuing Employees and their covered dependents to the extent such conditions were inapplicable, met or waived under the comparable employee plan in which such Continuing Employee participated immediately prior to the Effective Time; (iii) for purposes of each New Plan providing medical, dental, pharmaceutical, or vision benefits, to use commercially reasonable efforts to cause any eligible expenses incurred by the Continuing Employees and their covered dependents during the portion of the plan year of the Old Plan ending on the date that Continuing Employees’ participation in the corresponding New Plan begins to be given full credit for purposes of satisfying all deductible, coinsurance and maximum out-of-pocket requirements for the applicable plan year as if such amounts had been paid in accordance to the New Plan; and (iv) to credit the accounts of the Continuing Employees pursuant to any New Plan that is a flexible spending account plan with any unused balances in the account of such Continuing Employees under the Old Plan. Any vacation or paid time off accrued but unused by a Continuing Employee as of immediately prior to the Effective Time will be credited following the Effective Time and will not be subject to accrual limits or other forfeiture but will otherwise be subject to the terms of such applicable vacation or paid time off policies as determined by Parent and its affiliates from time to time.

Indemnification and Insurance

During the period commencing at the Effective Time and ending on the sixth anniversary of the Effective Time, the surviving corporation and its subsidiaries will, and Parent will cause the surviving corporation and its subsidiaries to, honor and fulfill, in all respects, the obligations of Instructure and its subsidiaries pursuant to any indemnification agreements between Instructure and any of its subsidiaries, on the one hand, and any of their respective current or former directors or officers (and any person who becomes a director or officer of Instructure or any of its subsidiaries prior to the Effective Time), on the other hand (each, together with such person’s heirs, executors and administrators, an “Indemnified Person” and, collectively, the “Indemnified Persons”), in each case, pursuant to an indemnification agreement in substantially the form filed as an exhibit to Instructure’s Form 10-K filed with the SEC on February 21, 2024. In addition, for a period of six years following the Effective Time, the surviving corporation or any of its subsidiaries will, and Parent will cause the surviving corporation and its subsidiaries to, cause all the organizational documents of the surviving corporation and its subsidiaries to contain provisions with respect to indemnification, exculpation and the advancement of expenses that are at least as favorable as the indemnification, exculpation and advancement of expenses provisions set forth in the organizational documents of the Company’s subsidiaries as of July 25, 2024, which provisions will not be repealed, amended or otherwise modified in any manner that would adversely affect the rights thereunder of any Indemnified Persons, except as required by applicable law during such six-year period.

For a period of six years following the Effective Time, the surviving corporation will, and Parent will cause the surviving corporation to, indemnify and hold harmless, to the fullest extent permitted by applicable law or the organizational documents of Instructure and any of its subsidiaries in effect on July 25, 2024, each Indemnified Person from and against all costs, fees and expenses, including, to the extent applicable, reasonable and documented attorneys’ fees and investigation expenses, judgments, fines, penalties, losses, claims, damages, liabilities and amounts paid in settlement or compromise in connection with any legal proceeding, whether civil, criminal, administrative or investigative, whenever asserted, to the extent that such legal proceeding arises, directly or indirectly, out of or pertains, directly or indirectly, to the fact that an Indemnified Person is or was a director or officer of Instructure or any such subsidiary at or prior to the Effective Time; or any action or omission, or alleged action or omission, in such Indemnified Person’s capacity as a director or officer of Instructure or any of its subsidiaries, or taken at the request of Instructure or such subsidiary, including in connection with serving at the request of the Instructure or such subsidiary as a director, officer, employee, agent,

67

trustee or fiduciary of another person (including any employee benefit plan), regardless of whether such action or omission, or alleged action or omission, occurred prior to or at the Effective Time; and the Merger, as well as any actions taken by Instructure, Parent or Merger Sub with respect to the Merger (including any dispositions of assets of the surviving corporation or any of its subsidiaries that is alleged to have rendered the surviving corporation or any of its subsidiaries insolvent).

If, at any time prior to the sixth anniversary of the Effective Time, any Indemnified Person delivers to Parent a written notice asserting such a claim for indemnification, then the claim asserted in such notice will survive the sixth anniversary of the Effective Time until such claim is fully and finally resolved. In the event of any such legal proceeding, the surviving corporation will advance all reasonable and documented fees and expenses (including reasonable and documented fees and expenses of any outside counsel) as incurred by an Indemnified Person in the defense of such legal proceeding. None of Parent, the surviving corporation nor any of their respective affiliates will settle or otherwise compromise or consent to the entry of any judgment with respect to, or otherwise seek the termination of, any legal proceeding for which indemnification may be sought by an Indemnified Person unless such settlement, compromise, consent or termination includes an unconditional release of all Indemnified Persons from all liability arising out of such legal proceeding to the fullest extent permitted under applicable law, subject to the surviving corporation’s receipt of an undertaking by or on behalf of such Indemnified Person to repay all amounts so advanced if it should ultimately be determined by final judicial decision from which there is no further right to appeal that such Indemnified Person is not entitled to be indemnified for such expenses.

For a period of six years following the Effective Time, the surviving corporation will, and Parent will cause the surviving corporation to, maintain in effect Instructure’s current directors’ and officers’ liability insurance in respect of acts or omissions occurring at or prior to the Effective Time on terms (including with respect to coverage, conditions, retentions, limits and amounts) that are equivalent to those of Instructure’s current directors’ and officers’ liability insurance; provided that in no event will the surviving corporation be obligated to pay annual premiums in excess of 300% of the amount paid by Instructure for coverage for its last full fiscal year, which amount is referred to as the maximum annual premium. If the annual premiums of such insurance coverage exceed the maximum annual premium, then the surviving corporation will be obligated to obtain a policy with the greatest coverage available for a cost not exceeding the maximum annual premium from an insurance carrier with the same or better credit rating as Instructure’s current directors’ and officers’ liability insurance carrier. In satisfaction of the foregoing obligations, prior to the Effective Time, Parent may purchase a prepaid “tail” policy with respect to Instructure’s current directors’ and officers’ liability insurance from an insurance carrier with the same or better credit rating as Instructure’s current directors’ and officers’ liability insurance carrier so long as the aggregate cost for such “tail” policy does not exceed the maximum annual premium; provided, that if the amount in respect of such “tail” policy exceeds such amount then Parent shall be obligated to obtain a policy with the greatest coverage available for a cost not exceeding the maximum annual premium. If Parent elects to purchase such a “tail” policy prior to the Effective Time, the surviving corporation will (and Parent will cause the surviving corporation to) maintain such “tail” policy in full force and effect for a period of no less than six years after the Effective Time and continue to honor its obligations under such “tail” policy. If Instructure is unable to obtain the “tail” policy and Parent or the surviving corporation are unable to obtain the insurance for an annual cost less than or equal to the maximum annual premium, Parent shall cause the surviving corporation to, instead obtain as much comparable insurance as possible for an aggregate annual premium equal to the maximum annual premium for such six year period.

Financing Covenant; Instructure Cooperation

Prior to the Effective Time, Instructure will use its reasonable best efforts, and will use its reasonable best efforts to cause each of its subsidiaries and its and their respective officers, directors, employees and other representatives, in each case, to provide all cooperation reasonably requested by Parent that is customary in connection with arranging and obtaining the Debt Financing, including: (i) reasonably cooperating with the marketing efforts of Parent and the Debt Financing sources, including participating (and causing senior

68

management and representatives, with appropriate seniority and expertise, of Instructure and its subsidiaries to participate) in a reasonable and limited number of meetings, presentations, bank meetings and sessions with rating agencies, due diligence sessions, drafting sessions, in each case, at mutually agreeable times in mutually agreeable locations (in each case, including via video conference) upon reasonable advance notice; (ii) solely with respect to financial information and data derived from Instructure’s historical books and records and maintained in the ordinary course of business, assisting to the extent reasonably necessary Parent and the Debt Financing sources with the timely preparation of customary rating agency presentations and bank information memoranda or memoranda (including a version that does not include material non-public information regarding Instructure or its subsidiaries) and other marketing materials, in each case, required in connection with the Debt Financing solely with respect to Instructure or its subsidiaries and otherwise providing Parent and the Debt Financing sources with such financial or other information regarding Instructure or its subsidiaries that is reasonably available or within the Instructure’s possession, in each case, reasonably requested by Parent and the Debt Financing sources in connection with the syndication, arrangement or marketing of the Debt Financing, it being agreed that Instructure will not be required to provide any information or assistance relating to (A) the proposed aggregate amount of debt and equity financing, together with assumed interest rates, dividends (if any) and fees and expenses relating to the incurrence of such debt or equity financing or (B) any post-closing or pro forma cost savings, synergies, capitalization, ownership or other pro forma adjustments desired to be incorporated into any information used in connection with the Debt Financing or (C) any financial information related to Parent or any of its subsidiaries or any adjustments that are not directly related to the acquisition of Instructure by Parent; (iii) assisting to the extent reasonably necessary Parent in connection with the preparation of the definitive financing documentation in respect of the Debt Financing, including a certificate of the chief financial officer of Instructure with respect to solvency matters in form and substance customary for debt financings of a type similar to the Debt Financing and disclosure schedules for any credit agreement, pledge, security and other financing documents as may be reasonably requested by Parent or the Debt Financing sources, and otherwise reasonably facilitating the pledging of collateral and the granting of security interests in respect of the Debt Financing, in each case, solely in respect of the Company and solely as required to be delivered at closing pursuant to the terms of the Debt Commitment Letter, it being understood that such documents will not take effect until the Effective Time; (iv) furnishing Parent and the Debt Financing sources, as applicable, with the (a) audited consolidated balance sheets of Instructure and its subsidiaries as of the end of, and related consolidated statements of operations, comprehensive income or loss, cash flows and stockholder’s equity of Instructure and its subsidiaries for, the three most recently completed fiscal years ended at least 90 days before the closing date, in each case in accordance with GAAP and (b) unaudited consolidated balance sheets of Instructure and its subsidiaries as of the end of, and related unaudited consolidated statements of operations, comprehensive income or loss, stockholders’ equity and cash flows of Instructure and its subsidiaries for each subsequent fiscal quarter (other than any fiscal fourth quarter) ended at least 45 days before the closing date after the most recent fiscal period for which audited financial statements have been provided, in each case prepared in accordance with GAAP; provided, that (x) the furnishing of such information on EDGAR or Instructure’s website shall constitute delivery thereof and (y) it is understood and agreed that the delivery of such information shall not be subject to any “reasonable best efforts” qualifier; (v) assisting with the payoff, discharge and termination of Instructure’s indebtedness and any other indebtedness contemplated to be repaid by the Debt Commitment Letter, including by arranging for, and reasonably facilitating, the delivery of customary pay-off letters, customary prepayment notices, lien terminations and instruments of discharge and providing other cooperation in connection with the repayment or other retirement of such Indebtedness, and the release and termination of any and all related liens, on or prior to the closing date; provided, that it is understood and agreed that the delivery of an executed payoff letter and lien terminations in respect of Instructure’s indebtedness shall not be subject to any “reasonable best efforts” qualifier and Instructure shall use reasonable best efforts to deliver drafts of the payoff letter and lien terminations no later than three business days prior to the closing date; (vi) no less than four business days prior to the closing date, furnishing Parent and the Debt Financing sources with all customary documentation and information reasonably available regarding Instructure required by regulatory authorities pursuant to applicable “know your customer” and anti-money laundering rules and regulations to the extent reasonably requested by Parent or the Debt Financing sources in writing at least nine business days prior to closing; provided, that it is understood and agreed that the delivery of such documentation and information

69

shall not be subject to any “reasonable best efforts” qualifier; (vii) providing executed customary authorization and representation letters to the Debt Financing sources authorizing the distribution of information to prospective lenders or investors and containing a representations to the Debt Financing sources that, among other things, the public side versions of such documents, if any, do not include material non-public information about Instructure or its subsidiaries or securities; provided, that it is understood and agreed that the delivery of such authorization and representation shall not be subject to any “reasonable best efforts” qualifier; and (viii) taking all corporate and, limited liability company or other actions, subject to the occurrence of the closing, reasonably requested by Parent to permit the consummation of the Debt Financing including, facilitating the execution and delivery at the Effective Time of definitive documents reasonably related to the Debt Financing in accordance with the terms contemplated by the Debt Commitment Letter (including, to the fullest extent permitted by applicable Law, distributing the proceeds of the Debt Financing, if any, obtained by any of its subsidiaries to the surviving corporation).

Additionally, such financing cooperation will not require Instructure or any of its subsidiaries to (i) waive or amend any terms of the Merger Agreement or agree to pay any fees or reimburse any expenses prior to the Effective Time for which it has not received prior reimbursement; (ii) enter into any definitive agreement (other than certain representation and authorization letters or any pay-off letter or prepayment notice contemplated in the Merger Agreement); (iii) give any indemnities in connection with the financing that are effective prior to the Effective Time; (iv) take any action that, in the good faith determination of Instructure, would unreasonably interfere with the conduct of the business or Instructure and its subsidiaries; (v) take any action that could reasonably be expected to result in a contravention of, violation or breach of, or default under, the Merger Agreement, any organizational document, material contract (in each case, excluding any actions that are conditioned on closing, and permitted pursuant to amendments to such documents made substantially concurrently with, and conditioned on, closing) or any material law; provided, that (1) the provision in any such organizational documents or agreements which would be breached or violated was not created in contemplation of the Merger or the Debt Financing and (2) Instructure and its subsidiaries shall work in good faith and use commercially reasonable efforts to resolve such contravention, violation, breach or default in order to permit the provision of the relevant cooperation; (vi) provide access to or disclose information which would result in waiving any attorney-client privilege, work-product or similar privilege and (vii) (A) contravene any position taken in any tax return or financial statements or (B) require Instructure to prepare any (1) pro forma financial statements or adjustments or projections or post-closing or pro forma cost savings, capitalization and other post-closing adjustments; (2) “description of notes” and “plan of distribution”; (3) risk factors relating to all or any component of the Financing; or (4) other information required by Rule 3-09, Rule 3-10 or Rule 3-16 of Regulation S-X, any Compensation, Discussion and Analysis required by Item 402(b) of Regulation S-K, any information required by Items 10 through 14 of Form 10-K or any other information customarily excluded from an offering memorandum for private placements of non-convertible high-yield bonds pursuant to Rule 144A or other information that is not reasonably available to Instructure under its current reporting systems or that Instructure does not maintain in the ordinary course of business. In addition, (A) no action, liability or obligation of Instructure, any of its subsidiaries or any of their respective representatives pursuant to any certificate, agreement, arrangement, document or instrument relating to the Debt Financing will be effective until the Effective Time (other than with respect to certain representation and authorization letters or any pay-off letter or prepayment notice contemplated in the Merger Agreement), and neither Instructure nor any of its subsidiaries or their respective representatives will be required to be an obligor pursuant to any certificate, agreement or instrument in connection with the Debt Financing that is not contingent on the occurrence of the closing or that must be effective prior to the Effective Time; and (B) any bank information memoranda and high-yield offering prospectuses or memoranda required in relation to the Debt Financing will contain disclosure and financial statements reflecting the surviving corporation or its subsidiaries as the obligor. Additionally, such financing cooperation will not require Instructure, its subsidiaries or their respective representatives to (1) pass resolutions or consents to approve or authorize the Debt Financing or the execution and delivery of the definitive documents that would be effective prior to the Effective Time, (2) take any action that could reasonably be expected to result in any representative of Instructure or any of its subsidiaries incurring personal liability (as opposed to liability in his or her capacity as an officer of such person) with respect to any matters related to the Debt Financing,

70

(3) incur any liability (or cause its directors, officers or employees to incur any liability) under the Debt Financing prior to the Effective Time or (4) cause the delivery of any legal opinions or any certificates, including as to solvency of Instructure or its subsidiaries; provided, that only officers or employees continuing in such roles after closing, and solely with respect to agreements contingent upon the closing and that would not be effective prior to the Effective Time shall be required to execute or enter into any of the foregoing.

Other Covenants and Agreements

The Merger Agreement contains other covenants and agreements, in which each of Parent and Instructure covenants or agrees to consult with each other before issuing, and give each other the opportunity to review and comment upon, any press release or other public statements with respect to the Merger and other transactions contemplated by the Merger Agreement, and shall not issue any such press release or make any such public statement prior to such consultation.

In addition, Instructure will, prior to the Effective Time:

Conditions to Consummation of the Merger

The obligation of each party to consummate the Merger is subject to the satisfaction (or waiver where permissible pursuant to applicable law) by each of the parties on or prior to the Closing of the following conditions:

71

As of the date of this information statement, the Written Consent has been received by Instructure.

The obligations of Parent and Merger Sub to consummate the Merger are further subject to satisfaction (or waiver by Parent where permissible pursuant to applicable law), at or prior to the closing of the following additional conditions:

72

The obligation of Instructure to consummate the Merger is further subject to satisfaction (or waiver by Instructure where permissible by applicable law) at or prior to the Effective Time of the following conditions:

Termination of the Merger Agreement

The Merger Agreement may be terminated at any time prior to the Effective Time (whether before or after receipt of the Written Consent) by the mutual written agreement of Parent and Instructure.

In addition, the Merger Agreement may be terminated by either Parent or Instructure, at any time prior to the Effective Time (whether prior to or after the receipt of the Written Consent):

73

Further, the Merger Agreement also provided that Parent could have terminated the Merger Agreement if (i) at any time prior to the receipt of the Written Consent, the Board had effected a Board Recommendation Change and (ii) if the Written Consent was not delivered to Parent and Instructure prior to 11:50 p.m., New York City Time, on July 26, 2024; however, these termination provisions expired following delivery of the Written Consent on July 25, 2024.

The Merger Agreement may also be terminated by Instructure at any time prior to the Effective Time (i) if all of the conditions to the obligations of Parent and Merger Sub are satisfied or waived (other than those conditions that by their terms are to be satisfied by actions taken at the closing, so long as such conditions are at the time of termination capable of being satisfied at the closing), (ii) Parent fails to consummate the transactions contemplated by the Merger Agreement by the date that is two business days after the first date on which Parent is required to consummate the closing, (iii) Instructure has irrevocably confirmed to Parent in writing that all conditions of the Company to consummate the closing have been satisfied (subject to customary exceptions) or that it is irrevocably waiving any such unsatisfied conditions and is prepared to consummate the closing and (iv) Parent fails to consummate the closing within three business days after the later of (x) the date on which the closing should have occurred pursuant to the Merger Agreement or (y) the date on which Parent receives the irrevocable confirmation of Instructure described in the foregoing clause (iii).

The Merger Agreement also provided that Instructure could have terminated the Merger Agreement, prior to receipt of the Written Consent (i) if Instructure received a Superior Proposal, (ii) the Board authorized Instructure to enter into a definitive alternative acquisition agreement to consummate the Acquisition Transaction contemplated by that Superior Proposal, (iii) Instructure complied in all material respects with respect to its obligations in connection with such Superior Proposal and (iv) Instructure paid as directed by Parent the Instructure Termination Fee; however, this termination provision expired following delivery of the Written Consent on July 25, 2024.

Termination Fees and Expenses

Instructure will pay to Parent (or its designee) the Instructure Termination Fee under the following circumstances:

74

Parent will pay Instructure the Parent Termination Fee in the event the Merger Agreement is terminated:

Superior Proposal and Change of Recommendation

Notwithstanding the restrictions set forth the section of this information statement captioned “The Merger Agreement—Termination Fees and Expenses” beginning on page 74, until the earlier to occur of the valid termination of the Merger Agreement and Parent’s receipt of the Written Consent, which was obtained on July 25, 2024, Instructure and the Board could have, directly or indirectly, participated or engaged in discussions or negotiations with, furnished any non-public information relating to Instructure or any of its subsidiaries to, or afforded access to the business, properties, assets, books, records or other non-public information or to any personnel, of Instructure or any of its subsidiaries pursuant to an acceptable confidentiality agreement to any person that had made, renewed or delivered to Instructure a bona fide written Acquisition Proposal after the date of execution of the Merger Agreement that did not result from a breach of Instructure’s obligations with respect thereto under the Merger Agreement and that the Board had determined in good faith (after consultation with its financial advisors and outside legal counsel) either constituted a Superior Proposal (as defined below) or could have been reasonably expected to lead to a Superior Proposal and the failure to do so would reasonably likely to be inconsistent with the director’s fiduciary duties under applicable law.

Except for the exceptions set forth below, which are no longer applicable, the Board will not (A) approve, recommend, cause or permit Instructure to enter into any agreement for the acquisition of Instructure, or authorize, resolve, agree or propose to take any such action or (B) take any of the following actions constituting a “Board Recommendation Change”:

75

Notwithstanding the restrictions set forth under the section of this information statement captioned “The Merger Agreement—Termination Fees and Expenses” beginning on page 74, until the earlier to occur of the valid termination of the Merger Agreement and Parent’s receipt of the Written Consent, which was obtained on July 25, 2024, the Board could have (i) made a Board Recommendation Change if the Board had determined in good faith (after consultation with its outside legal counsel and financial advisor) that, as a result of an Intervening Event (as defined below), failure to make such Board Recommendation Change would be reasonably likely to be inconsistent with Instructure’s directors’ fiduciary duties under applicable law or (ii) made a Board Recommendation Change, terminate the Merger Agreement, pay the Instructure Termination Fee to Parent (or its designee) and enter into a definitive written agreement with respect to an Acquisition Proposal, if Instructure had received an Acquisition Proposal after the date of the Merger Agreement for which the Board had determined in good faith (after consultation with its outside legal counsel and financial advisor) that such Acquisition Proposal constituted a Superior Proposal and that the failure to take such actions would be reasonably likely to be inconsistent with Instructure’s directors’ fiduciary duties under applicable law; provided, however, that the Board and any committee thereof could not have taken any action set forth above unless, prior to taking such action:

The Merger Agreement provides that the term “Superior Proposal” means any bona fide written Acquisition Proposal for an Acquisition Transaction on terms that the Board (or a committee thereof) has determined in good faith (after consultation with its financial advisors and outside legal counsel) would be reasonably likely to be consummated if accepted and, if consummated, would be more favorable from a financial point of view to Instructure’s stockholders than the Merger (taking into account any legal, regulatory, financial, timing, financing and other aspects of such proposal, including the identity of the person making the proposal, that the Board (or a committee thereof) considers in good faith to be relevant, and any revisions to the Merger Agreement, the Commitment Letters or the terms of the Debt Financing made or proposed in writing by Parent prior to the time of such determination). For purposes of the reference to an “Acquisition Proposal” in this definition, all references to “20%” in the definition of “Acquisition Transaction” shall be deemed to be references to “50%.”

The Merger Agreement provides that the term “Intervening Event” means any positive change, event, effect, development or circumstance (including any change in probability or magnitude of circumstances) that (i) is material to Instructure and its subsidiaries, taken as a whole, (ii) was not known or reasonably foreseeable to the Board on or prior to the date of the Merger Agreement (or, if known by the Board, the consequences of which were not known or reasonably foreseeable by the Board as of the date of the Merger Agreement) and (iii) does not relate to any Acquisition Proposal.

Instructure’s rights to engage in negotiations or discussions with third parties and to terminate the Merger Agreement as described above ceased on July 25, 2024 upon delivery of the Written Consent in accordance with the terms of the Merger Agreement.

76

Nothing contained in the Merger Agreement will prohibit Instructure or the Board from taking and disclosing to Instructure’s stockholders a position contemplated by Rule 14e-2(a) or Rule 14d-9 promulgated under the Exchange Act (or any substantially similar communication in connection with the making or amendment of a tender offer or exchange offer) or making a customary “stop-look-and-listen” communication to the Instructure stockholders pursuant to Rule 14d-9(f) under the Exchange Act (or any substantially similar communication) or from making factually accurate public disclosures to the Instructure stockholders pursuant to applicable securities laws or that describes Instructure’s receipt of an Acquisition Proposal and the operation of the Merger Agreement with respect thereto and no such communication by Instructure or the Board expressly permitted by the Merger Agreement shall be deemed a Board Recommendation Change.

Amendment and Waiver

The Merger Agreement may be amended by an instrument in writing signed on behalf of each of Parent, Merger Sub and Instructure (pursuant to authorized action by the Board (or a committee thereof)), except that in the event that Instructure has received the Written Consent, no amendment may be made to the Merger Agreement that requires the approval of the Instructure stockholders pursuant to the DGCL without such approval.

At any time prior to the Effective Time, Parent and Instructure may, to the extent legally allowed and except as otherwise provided in the Merger Agreement, (i) extend the time for the performance of any of the obligations or other acts of the other party, (ii) waive any inaccuracies in the representations and warranties of the other party contained in the Merger Agreement or in any document delivered pursuant to the Merger Agreement or (iii) subject to the requirements of applicable law, waive compliance by the other party with any of the agreements or conditions contained in the Merger Agreement. Any agreement on the part of a party to any such extension or waiver will be valid only if set forth in an instrument in writing signed by such party.

The delay in exercising any right pursuant to the Merger Agreement will not constitute a waiver of such rights.

Specific Performance; Jurisdiction

Subject to the limitations set forth in the Merger Agreement, the parties to the Merger Agreement are entitled, in addition to any other remedy to which they are entitled at law or in equity, to an injunction, specific performance, and other equitable relief to prevent breaches (or threatened breaches) of the Merger Agreement and to enforce specifically the performance of the terms and provisions of the Merger Agreement, without the requirement of providing any bond or other security in connection with such injunction or enforcement (and each party to the Merger Agreement has irrevocably waived any right it may have to require the obtaining, furnishing or posting of any such bond or other security). Each of the parties to the Merger Agreement has agreed not to raise any objections, other than those based on the limitations of a party’s right to such relief under the Merger Agreement, to (A) the granting of an injunction, specific performance or other equitable relief to prevent or restrain breaches or threatened breaches of the Merger Agreement by Instructure, on the one hand, or Parent and Merger Sub, on the other hand; and (B) the specific performance of the terms and provisions of the Merger Agreement to prevent breaches or threatened breaches of, or to enforce compliance with, the covenants, obligations and agreements of Parent and Merger Sub pursuant to the Merger Agreement.

Each party to the Merger Agreement has agreed to irrevocably submit to the exclusive general jurisdiction of the Court of Chancery of the State of Delaware and any state appellate court therefrom within the State of Delaware (or, if such court declines to accept jurisdiction over a particular matter, any state court within the State of Delaware or, if such state court declines to accept jurisdiction over a particular matter, any federal court within the State of Delaware), then in any Chosen Courts in the event that any dispute or controversy arises out of the Merger Agreement or the transactions contemplated in the Merger Agreement and has agreed that all claims with respect to such proceeding shall be brought, tried and determined only in such court. The parties to the Merger

77

Agreement have agreed that a final judgment in any such proceeding will be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law.

Governing Law

The Merger Agreement will be governed by, and construed in accordance with, the laws of the State of Delaware, regardless of the laws that might otherwise govern under applicable principles of conflicts of laws thereof.

78

MARKET INFORMATION AND DIVIDENDS

Company Common Stock began trading on the NYSE under the symbol “INST” on July 22, 2021. Prior to that, there was no public market for Company Common Stock. As of August 12, 2024, 146,471,276 shares of Company Common Stock were issued and outstanding, held by 76 stockholders of record.

Since the date of our initial public offering, we have not paid dividends on outstanding Company Common Stock. The terms of the Merger Agreement do not allow us to declare or pay a dividend between July 25, 2024 and the earlier of the consummation of the Merger or the termination of the Merger Agreement. Following the completion of the Merger, there will be no further market for the Company Common Stock.

79

APPRAISAL RIGHTS

General

Under the DGCL, you have the right to demand appraisal and to receive payment in cash for the fair value of your shares of Company Common Stock as determined by the Delaware Court of Chancery, together with interest, if any, as determined by the Delaware Court of Chancery, in lieu of the consideration you would otherwise be entitled to pursuant to the Merger Agreement, subject to the requirements and limitations set forth in Section 262 of the DGCL described herein. These rights are known as appraisal rights. Stockholders and beneficial owners electing to exercise appraisal rights must comply with the provisions of Section 262 of the DGCL in order to perfect their rights. Strict compliance with the statutory procedures is required to perfect appraisal rights under Delaware law.

This section is intended as a brief summary of the material provisions of Delaware law pertaining to appraisal rights. The following discussion, however, is not a complete summary of the law pertaining to appraisal rights under the DGCL and is qualified in its entirety by the full text of Section 262 of the DGCL that is accessible at the following publicly available website: https://delcode.delaware.gov/title8/c001/sc09/index.html#262. All references in Section 262 of the DGCL and in this summary to “stockholder” (and all references in this summary to “holder”) are to the record holder of the shares of Company Common Stock immediately prior to the Effective Time as to which appraisal rights are asserted. All references within Section 262 of the DGCL and this summary to “beneficial owner” mean the beneficial owner of shares of Company Common Stock held either in voting trust or by a nominee on behalf of such person. Failure to comply strictly with the procedures set forth in Section 262 of the DGCL will result in the loss of appraisal rights. The following discussion does not constitute any legal or other advice, nor does it constitute a recommendation as to whether or not an Instructure stockholder or beneficial owner should exercise its right to seek appraisal under Section 262 of the DGCL. In view of the complexity of the provisions of Section 262 of the DGCL, stockholders and beneficial owners wishing to exercise appraisal rights are urged to consult their legal and financial advisors before attempting to exercise such rights.

If the Merger is consummated, subject to certain exceptions specified in Section 262 of the DGCL and summarized below, holders and beneficial owners of shares of Company Common Stock who: (a) submit a proper written demand for appraisal of such shares to Instructure; (b) holds or beneficially owns such shares on the date of the making of such demand and continuously remain the record holders or beneficial owners, as the case may be, of such shares through the Effective Time; (c) otherwise comply with the applicable procedures and requirements set forth in Section 262 of the DGCL, (d) does not thereafter withdraw his, her or its demand for appraisal of such shares and (e) will be entitled to have their shares appraised by the Delaware Court of Chancery and receive payment in cash of the “fair value” of such shares (as determined by the Delaware Court of Chancery, exclusive of any element of value arising from the accomplishment or expectation of the Merger) as of the completion of the Merger instead of the Merger Consideration. Any such Instructure stockholder or beneficial owner awarded “fair value” for the holder’s shares by the court would receive payment of that fair value in cash, together with interest, if any, in lieu of the right to receive the Merger Consideration. It is possible that any such “fair value” as determined by the Delaware Court of Chancery may be more or less than, or the same as, that which Instructure stockholders will receive pursuant to the Merger Agreement.

When a merger agreement is approved by written consent without a meeting pursuant to Section 228 of the DGCL, as is the case with the Merger Agreement, Section 262 requires that either a constituent corporation before, or the surviving corporation within 10 days after, the effective date of the merger notify each of its stockholders who is entitled to appraisal rights that appraisal rights are so available and must include in each such notice a copy of Section 262 of the DGCL or information directing the stockholders to a publicly available electronic resource at which Section 262 of the DGCL may be accessed without subscription or cost. Such notice, if given on or after the effective date of the merger, must also notify the stockholders of the effective date of the merger.

80

This information statement constitutes our notice to Instructure’s stockholders of the availability of appraisal rights in connection with the Merger in compliance with the requirements of Section 262 of the DGCL and a copy of the applicable statutory provisions is accessible at the following publicly available website without subscription or cost: https://delcode.delaware.gov/title8/c001/sc09/index.html#262.

Stockholders or beneficial owners who wish to exercise appraisal rights or who wish to preserve the right to do so should review the following summary and the applicable statutory provisions carefully. Failure to comply with the procedures of Section 262 of the DGCL in a timely and proper manner will result in the loss of appraisal rights. In addition, the Delaware Court of Chancery will dismiss appraisal proceedings in respect of Instructure unless certain stock ownership conditions are satisfied by the Instructure stockholders and beneficial owners seeking appraisal. Because of the complexity of the procedures for exercising the right to seek appraisal, stockholders and beneficial owners who wish to exercise appraisal rights are urged to consult with their own legal and financial advisors in connection with compliance under Section 262 of the DGCL. An Instructure stockholder who loses his, her, their or its appraisal rights will be entitled to receive the Merger Consideration pursuant to and in accordance with the Merger Agreement.

How to Exercise and Perfect Your Appraisal Rights

If you are an Instructure stockholder or beneficial owner and wish to exercise the right to seek an appraisal of your shares of Company Common Stock, you must satisfy each of the following conditions:

If you fail to comply with any of these conditions and the Merger is completed, you will be entitled to receive the Merger Consideration pursuant to the terms of the Merger Agreement, but you will have no appraisal rights with respect to your shares of Company Common Stock.

81

In addition, because the Company Common Stock is listed on a national securities exchange and is expected to continue to be listed on such exchange immediately prior to the consummation of the Merger, the Delaware Court of Chancery will dismiss appraisal proceedings as to all holders and beneficial owners of shares of Company Common Stock who are otherwise entitled to appraisal rights, unless (a) the total number of shares entitled to appraisal exceeds 1% of the outstanding shares of Company Common Stock eligible for appraisal or (b) the value of the consideration provided in the Merger for such total number of shares entitled to appraisal exceeds $1 million. We refer to conditions (a) and (b) as the “ownership thresholds.” At least one of the ownership thresholds must be met in order for Company stockholders to be entitled to seek appraisal with respect to such shares of Company Common Stock.

Who May Exercise Appraisal Rights

A demand for appraisal must be executed by or on behalf of the stockholder of record or beneficial owner of the shares. The demand should set forth, fully and correctly, the name of the stockholder holding the shares in record name as it appears on the stock certificates (or in the stock ledger). The demand must reasonably inform Instructure of the identity of the record holder, or beneficial owner, as applicable, holding the shares for which appraisal is demanded and that the stockholder or beneficial owner intends to demand appraisal of his, her or its shares of Company Common Stock. In addition, if a demand is made by a beneficial owner, the demand must (a) reasonably identify the holder of record of the shares for which the demand is made, (b) provide documentary evidence of such beneficial owner’s beneficial ownership and a statement that such documentary evidence is a true and correct copy of what it purports to be and (c) provide an address at which such beneficial owner consents to receive notices given by the surviving corporation and the office of Register in Chancery and to be set forth on the verified list required by Section 262(f) of the DGCL. A holder of record, such as a bank, broker or other nominee, who holds shares of Company Common Stock as a nominee or intermediary for others, may exercise his, her or its right of appraisal with respect to the shares of Company Common Stock held for one or more beneficial owners, while not exercising this right for other beneficial owners. In that case, the written demand should state the number of shares of Company Common Stock as to which appraisal is sought. Where no number of shares of Company Common Stock is expressly mentioned, the demand will be presumed to cover all shares of Company Common Stock held in the name of the holder of record or beneficially owned by the beneficial owner.

If you own shares of Company Common Stock jointly with one or more other persons, as in a joint tenancy or tenancy in common, the demand for appraisal should be executed by or for you and all other joint owners. An authorized agent, including an agent for two or more joint owners, may execute the demand for appraisal for a stockholder of record; however, the agent must identify the holder or holders of record and expressly disclose the fact that, in exercising the demand, such person is acting as an agent.

If you elect to exercise appraisal rights under Section 262 of the DGCL, you should mail or deliver a written demand to:

Instructure Holdings, Inc.

6330 South 3000 East, Suite 700

Salt Lake City, Utah 84121

Attention: Chief Legal Officer

Surviving Corporation’s Actions After Completion of the Merger

If the Merger is consummated, the surviving corporation will give written notice of the Effective Time within ten days after the Effective Time to all of the Instructure stockholders and beneficial owners that are entitled to appraisal rights; provided, however, that if such notice is sent more than 20 days following the sending of this information statement, such notice need only be sent to each holder and beneficial owner who is entitled to appraisal rights and who has demanded appraisal of his, her or its shares of Company Common Stock in

82

accordance with Section 262 of the DGCL. At any time within 60 days after the Effective Time, any person entitled to appraisal rights who did not commence an appraisal proceeding or join in such a proceeding as a named party will have the right to withdraw such person’s demand and to accept the Merger Consideration in accordance with the Merger Agreement for his, her or its shares of Company Common Stock. In addition, no appraisal proceeding in the Delaware Court of Chancery will be dismissed as to any stockholder or beneficial owner without the approval of the Delaware Court of Chancery, which approval may be conditioned on the terms the Delaware Court of Chancery deems just (including without limitation, a reservation of jurisdiction for any application to the Delaware Court of Chancery made with respect to the allocation of the expenses of the proceeding); provided, however, that this will not affect the right of any Instructure stockholder or beneficial owner that has made an appraisal demand but who has not commenced an appraisal proceeding or joined such proceeding as a named party to withdraw such stockholder’s or beneficial owner’s demand for appraisal and to accept the terms and the Merger Consideration offered in the Merger within 60 days after the Effective Time. Within 120 days after the Effective Time, either a record holder or a beneficial owner of Company Common Stock, provided such person has complied with the requirements of Section 262 of the DGCL and is otherwise entitled to appraisal rights, or the surviving corporation may commence an appraisal proceeding by filing a petition in the Delaware Court of Chancery, with a copy served on the surviving corporation in the case of a petition filed by a stockholder or beneficial owner, demanding an appraisal of the fair value of the shares of Company Common Stock held by all persons who have properly demanded appraisal. The surviving corporation is under no obligation to file an appraisal petition and has no present intention of doing so. If you desire to have your shares appraised, you should initiate any petitions necessary for the perfection of your appraisal rights within the time periods and in the manner prescribed in Section 262 of the DGCL. If, within 120 days after the Effective Time, no petition has been filed as provided in Section 262 of the DGCL, all rights to appraisal will cease and any person who previously demanded appraisal will become entitled only to the Merger Consideration, in accordance with and pursuant to the terms of the Merger Agreement.

Within 120 days after the Effective Time, any stockholder or beneficial owner who has complied with the provisions of Section 262 of the DGCL will be entitled to receive from the surviving corporation, upon written request, a statement setting forth the aggregate number of shares of Company Common Stock with respect to which Instructure has received demands for appraisal, and the aggregate number of holders or beneficial owners holding or owning those shares (for which purpose the record holder of shares held by a beneficial owner who has made a demand for appraisal shall not be considered a separate stockholder holding such shares). The surviving corporation must give this statement to you within the later of (a) ten days after receipt by the surviving corporation of the request therefor or (b) ten days after expiration of the period for delivery of demands for appraisal.

If a petition for appraisal is duly filed by you or another holder of record or beneficial owner of Company Common Stock who has properly exercised his, her or its appraisal rights in accordance with the provisions of Section 262 of the DGCL, and a copy of the petition is delivered to the surviving corporation, the surviving corporation will then be obligated, within 20 days after receiving service of a copy of the petition, to file in the office of the Register in Chancery in which the petition was filed a duly verified list containing the names and addresses of all holders and beneficial owners who have demanded appraisal of their shares and with whom agreements as to the value of their shares have not been reached by the surviving corporation. Upon the filing of any such petition, the Delaware Court of Chancery may order that notice of the time and place fixed for the hearing on the petition be mailed, by registered or certified mail, to the surviving corporation and all persons shown on the verified list at the addresses stated therein. The costs of these notices are borne by the surviving corporation. After notice to persons who demanded appraisal of their shares of Company Common Stock as may be required by the court, the Delaware Court of Chancery is empowered to conduct a hearing on the petition to determine those persons who have complied with Section 262 and who have become entitled to appraisal thereunder. The Delaware Court of Chancery will then determine which stockholders and beneficial owners are entitled to appraisal rights and may require the persons demanding appraisal for their shares represented by certificates to submit their stock certificates to the Register in Chancery for notation thereon of the pendency of the appraisal proceedings, and the Delaware Court of Chancery may dismiss the proceedings as to any such

83

person who fails to comply with this direction. The Delaware Court of Chancery will also dismiss proceedings as to all Instructure stockholders and beneficial owners if neither of the ownership thresholds described above is met. Where proceedings are not dismissed or the demand for appraisal is not successfully withdrawn, the appraisal proceeding will be conducted as to the shares of Company Common Stock for which the applicable stockholders and beneficial owners thereof are entitled to appraisal, in accordance with the rules of the Delaware Court of Chancery, including any rules specifically governing appraisal proceedings. The Delaware Court of Chancery will thereafter determine the fair value of such shares of Company Common Stock at the Effective Time, exclusive of any element of value arising from the accomplishment or expectation of the Merger, together with interest, if any, to be paid upon the amount determined to be fair value. Unless the Delaware Court of Chancery in its discretion determines otherwise for good cause shown, interest from the Effective Time through the date of payment of the judgment will be compounded quarterly and will accrue at 5% over the Federal Reserve discount rate (including any surcharge) as established from time to time during the period between the Effective Time and the date of payment of the judgment. However, the surviving corporation has the right, at any point prior to the Delaware Court of Chancery’s entry of judgment in the proceedings, to make a voluntary cash payment to each person entitled to appraisal. Notwithstanding the foregoing or anything herein to the contrary, if the surviving corporation makes a voluntary cash payment at any time before the entry of judgment in the appraisal proceeding pursuant to subsection (h) of Section 262 of the DGCL, interest will accrue thereafter only on the sum of (a) the difference, if any, between the amount paid by the surviving corporation in such voluntary cash payment and the fair value of the shares as determined by the Delaware Court of Chancery and (b) interest accrued on the amount of the voluntary cash payment before such payment was made, unless such interest was paid at the time the voluntary cash payment is made. Upon application by the surviving corporation or by any person entitled to participate in the appraisal proceeding, the Delaware Court of Chancery may, in its discretion, proceed to trial upon the appraisal prior to the final determination of the persons entitled to an appraisal. Any person whose name appears on the verified list may participate fully in all proceedings until it is finally determined that such person is not entitled to appraisal rights. When the value is determined, the Delaware Court of Chancery will direct the payment of such value, less any amounts already paid in a voluntary cash payment, with interest thereon, if any, to the persons entitled to receive the same. Payment shall be so made to each such person upon such terms and conditions as the Delaware Court of Chancery may order.

In determining the fair value, the Delaware Court of Chancery is required to take into account all relevant factors. In Weinberger v. UOP, Inc., the Delaware Supreme Court discussed the factors that could be considered in determining fair value in an appraisal proceeding, stating that “proof of value by any techniques or methods which are generally considered acceptable in the financial community and otherwise admissible in court” should be considered and that “[f]air price obviously requires consideration of all relevant factors involving the value of a company.”

The Delaware Supreme Court has stated that, in making this determination of fair value, the court must consider market value, asset value, dividends, earnings prospects, the nature of the enterprise and any other factors which were known, or which could be ascertained as of the date of the Merger which throw any light on future prospects of the merged corporation. The Delaware Supreme Court has recently indicated that transaction price is one of the relevant factors the Delaware Court of Chancery may consider in determining fair value and that absent deficiencies in the sale process the transaction price may be given “considerable weight.” Section 262 of the DGCL provides that fair value is to be “exclusive of any element of value arising from the accomplishment or expectation of the merger.” In Cede & Co. v. Technicolor, Inc., the Delaware Supreme Court stated that such exclusion is a “narrow exclusion [that] does not encompass known elements of value,” but which rather applies only to the speculative elements of value arising from such accomplishment or expectation. In Weinberger, the Delaware Supreme Court construed Section 262 of the DGCL to mean that “elements of future value, including the nature of the enterprise, which are known or susceptible of proof as of the date of the merger and not the product of speculation, may be considered.”

You should be aware that the fair value of your shares of Company Common Stock as determined under Section 262 of the DGCL could be more than, the same as, or less than the value that you are entitled to receive

84

under the terms of the Merger Agreement and that an opinion of an investment banking firm as to the fairness from a financial point of view of the consideration payable in a merger is not an opinion as to, and does not in any manner address, fair value under Section 262 of the DGCL.

Moreover, neither Instructure nor Parent anticipates offering more than the Per Share Price to any Instructure stockholder or beneficial owner exercising appraisal rights and reserves the right to make a voluntary cash payment pursuant to subsection (h) of Section 262 of the DGCL and to assert, in any appraisal proceeding, that, for purposes of Section 262, the “fair value” of a share of Company Common Stock is less than the Per Share Price. No representation is made as to the outcome of the appraisal of fair value as determined by the Delaware Court of Chancery.

If no party files a petition for appraisal within 120 days after the Effective Time or if neither of the ownership thresholds above has been satisfied in respect of such shares, then all Instructure stockholders and beneficial owners will lose the right to an appraisal and will instead receive the Per Share Price described in the Merger Agreement, in accordance with and pursuant to the terms thereof.

The Delaware Court of Chancery may determine the costs of the appraisal proceeding and may tax those costs to the parties as the Delaware Court of Chancery determines to be equitable under the circumstances. Upon application of any person whose name appears on the verified list filed by the surviving corporation who participated in the proceeding and incurred expenses in connection therewith, the Delaware Court of Chancery may order all or a portion of such expenses, including, without limitation, reasonable attorneys’ fees and the fees and expenses of experts, to be charged pro rata against the value of all shares of Company Common Stock entitled to appraisal not dismissed pursuant to Section 262(k) of the DGCL or subject to such an award pursuant to a reservation of jurisdiction under Section 262(k) of the DGCL. In the absence of such an order, each party to the appraisal proceeding bears its own expenses of its attorneys and experts.

If you have duly demanded appraisal in compliance with Section 262 of the DGCL you may not, on or after the Effective Time, vote the shares subject to the demand for any purpose or receive any dividends or other distributions on those shares, except dividends or other distributions payable to holders of record of Company Common Stock as of a record date prior to the Effective Time.

If a person who has made a demand for an appraisal in accordance with Section 262 shall deliver to the surviving corporation a written withdrawal of such person’s demand for an appraisal in respect of some or all of such person’s shares of Company Common Stock in accordance with subsection (e) of Section 262, either within 60 days after the Effective Time or thereafter with the written approval of the surviving corporation, then the right of such person to an appraisal of such shares subject to the withdrawal will cease. Notwithstanding the foregoing, an appraisal proceeding in the Delaware Court of Chancery shall not be dismissed as to any person without the approval of the Delaware Court of Chancery, and such approval may be conditioned upon such terms as the Delaware Court of Chancery deems just, including without limitation, a reservation of jurisdiction for any application to the Delaware Court of Chancery made under subsection (j) of Section 262; provided, however, that any person who has not commenced an appraisal proceeding or joined such proceeding as a named party may withdraw such person’s demand for appraisal and to accept the terms and the Per Share Price offered in the Merger within 60 days after the Effective Time. If you fail to perfect, successfully withdraw your demand for appraisal, or lose the appraisal right, your shares of Company Common Stock will be converted into the right to receive the Per Share Price, in accordance with and pursuant to the Merger Agreement without interest thereon.

Failure to follow the steps required by Section 262 of the DGCL for perfecting appraisal rights will result in the loss of your appraisal rights. In that event, you will be entitled to receive the Per Share Price for your shares of Company Common Stock in accordance with the Merger Agreement without interest. In view of the complexity of the provisions of Section 262 of the DGCL, if you are an Instructure stockholder or beneficial owner and are considering exercising your appraisal rights under the DGCL, you are urged to consult your own legal and financial advisor.

85

Holders and beneficial owners of Company Common Stock considering seeking to exercise their appraisal rights should be aware that the fair value of their shares of Company Common Stock as determined under Section 262 could be more than, the same as or less than the consideration they would receive pursuant to the Merger if they did not seek appraisal of their shares of Company Common Stock. Failure to comply strictly with all of the procedures set forth in Section 262 will result in a loss of statutory appraisal rights. The process of demanding and exercising appraisal rights requires compliance with the prerequisites of Section 262 of the DGCL.

Consequently, and in view of the complexity of the provisions of Section 262, if you wish to exercise your appraisal rights, you are urged to consult with your own legal and financial advisors in connection with compliance under Section 262 of the DGCL. To the extent there are any inconsistencies between the foregoing summary and Section 262 of the DGCL, the DGCL will govern.

86

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The following table sets forth information about the beneficial ownership of Company Common Stock as of August 12, 2024 for:

The numbers of shares of Company Common Stock beneficially owned and percentages of beneficial ownership are based on 146,471,276 shares of Company Common Stock outstanding as of August 12, 2024.

Beneficial ownership for the purposes of the following table is determined in accordance with the rules and regulations of the SEC. These rules generally provide that a person is the beneficial owner of securities if such person has or shares the power to vote or direct the voting thereof, or to dispose or direct the disposition thereof or has the right to acquire such powers within 60 days. Company Common Stock subject to options or RSUs that are currently exercisable or exercisable or will vest within 60 days of August 12, 2024 are deemed to be outstanding and beneficially owned by the person holding the options or RSUs. These shares, however, are not deemed outstanding for the purposes of computing the percentage ownership of any other person. Except as disclosed in the footnotes to this table and subject to applicable community property laws, we believe that each stockholder identified in the table possesses sole voting and investment power over all Company Common Stock shown as beneficially owned by the stockholder.

Unless otherwise noted below, the address of each beneficial owner listed on the table is c/o Instructure Holdings, Inc., 6330 South 3000 East, Suite 700, Salt Lake City, UT 84121.

87

88

WHERE YOU CAN FIND MORE INFORMATION

We file annual, quarterly and current reports, proxy statements and other documents with the SEC. These reports contain additional information about Instructure. Instructure’s SEC filings are made electronically available to the public at the SEC’s website located at www.sec.gov. Stockholders can also obtain free copies of our SEC filings through the “SEC Filings” section of Instructure’s website at https://ir.instructure.com/financials/sec-filings/default.aspx. Our website address is being provided as an inactive textual reference only. The information provided on, or accessible through, our website, other than the copies of the documents listed or referenced below that have been or will be filed with the SEC, is not part of this information statement, and therefore is not incorporated herein by reference.

The SEC allows Instructure to “incorporate by reference” information that it files with the SEC in other documents into this information statement. This means that Instructure may disclose important information to you by referring you to another document filed separately with the SEC. The information incorporated by reference is considered to be part of this information statement. This information statement and the information that Instructure files later with the SEC may update and supersede the information incorporated by reference. Such updated and superseded information will not, except as so modified or superseded, constitute part of this information statement.

Instructure incorporates by reference in this information statement each document it files under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of the initial filing of this information statement and before the Effective Time. Instructure also incorporates by reference in this information statement the following documents filed by it with the SEC under the Exchange Act:

Instructure undertakes to provide without charge to each person to whom a copy of this information statement has been delivered, upon written or oral request, by first class mail or other equally prompt means within one business day of receipt of such request, a copy of any or all of the documents incorporated by reference in this information statement, other than the exhibits to these documents, unless the exhibits are specifically incorporated by reference into the information that this information statement incorporates. You may request a copy of these filings by telephone at (800) 203-6755 or by writing to us at:

Investor Relations

6330 South 3000 East, Suite 700

Salt Lake City, Utah 84121

e-mail: investors@instructure.com

Parent, Merger Sub and KKR have supplied, and Instructure has not independently verified, the information in this information statement relating to Parent, Merger Sub and KKR.

Stockholders should not rely on information that purports to be made by or on behalf of Instructure other than that contained in or incorporated by reference in this information statement. Instructure has not authorized anyone to provide information on behalf of Instructure that is different from that contained in this information statement. This information statement is dated    . No assumption should be made that the information contained in this information statement is accurate as of any date other than that date, and the mailing of this information statement will not create any implication to the contrary.

89

Annex A

Execution Version

AGREEMENT AND PLAN OF MERGER

by and among

ICON PARENT INC.,

ICON ACQUISITION SUB INC.

and

INSTRUCTURE HOLDINGS, INC.

Dated as of July 25, 2024

TABLE OF CONTENTS

A-i

A-ii

EXHIBITS

A-iii

AGREEMENT AND PLAN OF MERGER

THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of July 25, 2024, by and among Icon Parent Inc., a Delaware corporation (“Parent”), Icon Acquisition Sub Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”), and Instructure Holdings, Inc., a Delaware corporation (the “Company”). Each of Parent, Merger Sub and the Company are sometimes referred to herein as a “Party.” All capitalized terms that are used in this Agreement have the respective meanings given to them in this Agreement.

RECITALS

A. The Company Board has unanimously (i) determined that it is fair to, and in the best interests of, the Company and the Company Stockholders, and declared it advisable, to enter into this Agreement providing for the merger of Merger Sub with and into the Company (the “Merger”), with the Company being the surviving corporation in the Merger, in accordance with the General Corporation Law of the State of Delaware (the “DGCL”) upon the terms and subject to the conditions set forth herein; (ii) approved and declared advisable this Agreement, the execution and delivery of this Agreement by the Company, the performance by the Company of its covenants and other obligations hereunder, and the consummation of the Merger and the other Transactions upon the terms and subject to the conditions set forth herein; and (iii) resolved to recommend that the Company Stockholders adopt this Agreement in accordance with the DGCL.

B. Each of the board of directors of Parent and the board of directors of Merger Sub have unanimously (i) declared it advisable to enter into this Agreement; and (ii) approved the execution and delivery of this Agreement, the performance of their respective covenants and other obligations hereunder, and the consummation of the Merger upon the terms and subject to the conditions set forth herein.

C. Concurrently with the execution and delivery of this Agreement, and as a condition and inducement to the Company’s willingness to enter into this Agreement, Parent and Merger Sub have delivered a guarantee (the “Guarantee”) from KKR North America Fund XIII SCSp, a Luxembourg special limited partnership (“Guarantor”), in favor of the Company and pursuant to which, subject to the terms and conditions contained therein, Guarantor is guaranteeing certain obligations of Parent and Merger Sub in connection with this Agreement.

D. Parent, Merger Sub and the Company desire to (i) make certain representations, warranties, covenants and agreements in connection with this Agreement and the Merger; and (ii) prescribe certain conditions with respect to the consummation of the Merger.

AGREEMENT

NOW, THEREFORE, in consideration of the foregoing premises and the representations, warranties, covenants and agreements set forth herein, as well as other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged and accepted, and intending to be legally bound hereby, Parent, Merger Sub and the Company agree as follows:

ARTICLE I

DEFINITIONS & INTERPRETATIONS

1.1 Certain Definitions. For all purposes of and pursuant to this Agreement, the following capitalized terms have the following respective meanings:

(a) “Acceptable Confidentiality Agreement” means any confidentiality agreement (x) in effect as of the date hereof or (y) executed, delivered and effective after the date hereof and containing terms that are not

A-1

materially less favorable in the aggregate to the Company than those contained in the Confidentiality Agreement, except that such confidentiality agreement need not contain any “standstill” or similar provision or otherwise prohibit the making of any Acquisition Proposal.

(b) “Acquisition Proposal” means any offer or proposal (other than an offer or proposal by Parent or Merger Sub) relating to an Acquisition Transaction.

(c) “Acquisition Transaction” means any transaction or series of related transactions (other than the Merger) involving:

(i) any direct or indirect purchase or other acquisition by any Person or Group, whether from the Company or any other Person(s), of shares of Company Common Stock representing more than 20% of the Company Common Stock outstanding (by vote or economic interests) after giving effect to the consummation of such purchase or other acquisition, including pursuant to a tender offer or exchange offer by any Person or Group that, if consummated in accordance with its terms, would result in such Person or Group beneficially owning more than 20% of the Company Common Stock outstanding after giving effect to the consummation of such tender or exchange offer;

(ii) any direct or indirect purchase or other acquisition by any Person or Group, or stockholders of any such Person or Group, of more than 20% of the consolidated assets, net revenue or net income of the Company and its Subsidiaries taken as a whole (measured by the fair market value thereof);

(iii) any merger, consolidation, business combination, recapitalization, reorganization, liquidation, dissolution or other transaction involving the Company or any of its Subsidiaries pursuant to which any Person or Group, or stockholders of any such Person or Group, would hold, directly or indirectly, more than 20% of the equity interests of the surviving or resulting entity of such transaction after giving effect to the consummation of such transaction; or

(iv) any combination of the foregoing.

(d) “Affiliate” means, with respect to any Person, any other Person that, directly or indirectly, controls, is controlled by or is under common control with such Person. For purposes of this definition, the term “control” (including, with correlative meanings, the terms “controlling,” “controlled by” and “under common control with”), as used with respect to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of that Person, whether through the ownership of voting securities or partnership or other ownership interests, by contract or otherwise. For the avoidance of doubt, none of the Specified Stockholders or any investment funds or investment vehicles affiliated with or under common management with the Specified Stockholders, any portfolio company (as such term is commonly understood in the private equity industry) or investment of the Specified Stockholders or any other Person that would otherwise be an Affiliate of the Specified Stockholders pursuant to this definition shall be an “Affiliate” of the Company or any of its Subsidiaries; provided, that this sentence shall not apply with respect to the definitions of “Company Related Parties” or “Transaction Litigation”, Section 3.27, Section 4.17, Section 5.2(xv), Section 5.3(a), Section 6.2, Section 6.4, Section 6.5, Section 8.2(b), Section 9.12, the Equity Commitment Letter or the Guarantee.

(e) “Anti-Corruption Laws” means (i) the U.S. Foreign Corrupt Practices Act of 1977 (as amended), (ii) the United Kingdom Bribery Act, (iii) anti-bribery legislation promulgated by the European Union and implemented by its member states, (iv) legislation adopted in furtherance of the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, and (v) other anti-bribery and anti-corruption laws, regulations or ordinances applicable to the Company and its Subsidiaries and their respective operations from time to time.

(f) “Anti-Money Laundering Laws” means anti-money laundering-related laws, regulations, and codes of practice applicable to the Company and its Subsidiaries and their operations from time to time,

A-2

including without limitation (i) the EU Anti-Money Laundering Directives and any laws, decrees, administrative orders, circulars, or instructions implementing or interpreting the same, and (ii) the applicable financial recordkeeping and reporting requirements of the U.S. Currency and Foreign Transaction Reporting Act of 1970, as amended.

(g) “Antitrust Law” means the Sherman Antitrust Act of 1890, the Clayton Antitrust Act of 1914, the HSR Act, the Federal Trade Commission Act of 1914, and all other Laws, in any jurisdiction, whether domestic or foreign, in each case that are designed or intended to prohibit, restrict or regulate actions having the purpose or effect of monopolization or restraint of trade or significant impediments or lessening of competition or the creation or strengthening of a dominant position through merger or acquisition, in any case that are applicable to the Merger.

(h) “Audited Company Balance Sheet” means the consolidated balance sheet (and the notes thereto) of the Company and its consolidated Subsidiaries as of December 31, 2023 set forth in the Company’s Form 10-K filed by the Company with the SEC on February 21, 2024.

(i) “Business Day” means any day other than Saturday or Sunday or a day on which commercial banks are authorized or required by Law to be closed in New York, New York.

(j) “Bylaws” means the Amended and Restated Bylaws of the Company.

(k) “CARES Act” means the Coronavirus Aid, Relief and Economic Security Act, as signed into law by the President of the United States on March 27, 2020.

(l) “Charter” means the Second Amended and Restated Certificate of Incorporation of the Company.

(m) “Code” means the Internal Revenue Code of 1986.

(n) “Company Board” means the Board of Directors of the Company.

(o) “Company Common Stock” means the common stock, par value $0.01 per share, of the Company.

(p) “Company Credit Agreement” means the Credit Agreement, dated as of October 29, 2021, by and among the Company, as borrower, each lender from time to time party thereto, JPMorgan Chase Bank, N.A., as administrative agent and collateral agent (as amended by the First Amendment to Credit Agreement, dated as of June 7, 2023, and the Second Amendment to Credit Agreement, dated as of February 1, 2024).

(q) “Company ESPP” means the Instructure Holdings, Inc. 2021 Employee Stock Purchase Plan, as amended from time to time.

(r) “Company Indebtedness” means, collectively, debt outstanding under the Company Credit Agreement.

(s) “Company Intellectual Property” means any Intellectual Property that is owned, or purported to be owned, by the Company or any of its Subsidiaries.

(t) “Company Material Adverse Effect” means any change, event, effect, occurrence or development that, individually or in the aggregate, has or would reasonably be expected to have a material adverse effect on the business, financial condition, assets, liabilities or results of operations of the Company and its Subsidiaries, taken as a whole; provided, that none of the following, and no conditions, changes, events, effects, occurrences or developments arising out of, relating to or resulting from the following (in each case, by itself or when aggregated) will be deemed to be or constitute a Company Material Adverse Effect or will be taken into account

A-3

when determining whether a Company Material Adverse Effect has occurred (subject to the limitations set forth below):

(i) general economic conditions, or conditions in the global, international or regional economy generally, including changes in inflation, supply chain disruptions, and labor shortages;

(ii) conditions in the equity, credit, debt, financial, currency or capital markets, including (A) changes in interest rates or credit ratings; (B) changes in exchange rates for the currencies of any country; or (C) any suspension of trading in securities (whether equity, debt, derivative or hybrid securities) generally on any securities exchange or over-the-counter market;

(iii) conditions in the industries in which the Company and its Subsidiaries conduct business or in any specific jurisdiction or geographical area in which the Company conducts business, or changes therein;

(iv) any political or geopolitical conditions, outbreak of hostilities, armed conflicts, acts of war (whether or not declared), rebellion, insurrection, sabotage, cyber-attack, cyberterrorism (including by means of cyber-attack by or sponsored by a Governmental Authority) terrorism or military actions, including any escalation or worsening of the foregoing or any threats thereof, in each case, in the United States or any other country or region in the world;

(v) earthquakes, volcanic activity, hurricanes, tsunamis, tornadoes, floods, mudslides, wild fires, nuclear incidents, foreign or domestic social protest or social unrest (whether or not violent) or other natural or man-made disasters, weather conditions, power outages or electrical black-outs, and other force majeure events, including any escalation or worsening of any of the foregoing, in each case, in the United States or any other country or region in the world;

(vi) the negotiation, execution, delivery or performance of this Agreement or the announcement of this Agreement or the pendency of the Merger, including the impact thereof on the relationships, contractual or otherwise, of the Company and its Subsidiaries with customers, suppliers, lenders, lessors, business partners, employees (including any employee attrition), regulators, Governmental Authorities, vendors or any other third Person (other than for purposes of the representations and warranties contained in Section 3.5 and Section 3.6 and the related conditions to Closing set forth in Section 7.3(a));

(vii) the compliance by the Company with the express terms of this Agreement, including any action taken or refrained from being taken pursuant to or in accordance with the express terms of this Agreement (other than Section 5.1);

(viii) any action taken or refrained from being taken, in each case to which Parent has approved, consented to or requested in writing following the date of this Agreement;

(ix) changes after the date hereof in GAAP or other accounting standards, in any applicable Laws (or the enforcement or publicly available interpretation of any of the foregoing) or in any regulatory or legislative conditions, including the adoption, implementation, repeal, modification, or publicly available reinterpretation of any Law, regulation or policy (or the enforcement thereof) by any Governmental Authority, or any panel or advisory body empowered or appointed thereby;

(x) any epidemics, pandemics (including COVID-19 and any evolutions or mutations thereof), plagues, other outbreaks of illness or public health events (including quarantine restrictions), including any escalation or worsening of any of the foregoing, in each case, in the United States or any other country or region in the world;

(xi) any COVID-19 Measures;

A-4

(xii) any anti-dumping actions, international tariffs, sanctions, trade policies or disputes or any “trade war” or similar actions in connection with any dispute involving the Russian Federation and Ukraine;

(xiii) any changes in the price or trading volume of the Company Common Stock, in and of itself (it being understood that the underlying cause of such change may be taken into consideration when determining whether a Company Material Adverse Effect has occurred to the extent not otherwise excluded hereunder);

(xiv) any failure by the Company and its Subsidiaries to meet (A) any public estimates or expectations of the Company’s revenue, earnings or other financial performance or results of operations for any period; or (B) any budgets, plans, projections or forecasts of its revenues, earnings or other financial performance or results of operations (it being understood that the underlying cause of any such failure may be taken into consideration when determining whether a Company Material Adverse Effect has occurred to the extent not otherwise excluded hereunder);

(xv) the availability or cost of equity, debt or other financing to Parent or Merger Sub;

(xvi) any Transaction Litigation or any demand or Legal Proceeding for appraisal of the fair value of any shares of Company Common Stock pursuant to the DGCL in connection herewith;

(xvii) the identity of, or any facts or circumstances relating to, Guarantor, Parent, Merger Sub, or the respective Affiliates of the foregoing, the respective Financing Sources of or investors in the foregoing, or the respective plans or intentions of the foregoing, with respect to the Company or its business; and

(xviii) any breach by Parent or Merger Sub of this Agreement,

except, in each case of clauses (i), (ii), (iii), (iv), (v), (ix), (x), (xi) and (xii) to the extent that such conditions, changes, events, effects, occurrences or developments have had a materially disproportionate adverse effect on the Company and its Subsidiaries, taken as a whole, relative to other companies operating in the industries in which the Company and its Subsidiaries conduct business, in which case only the incremental disproportionate adverse impact may be taken into account in determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur.

(u) “Company Preferred Stock” means the preferred stock, par value $0.01 per share, of the Company.

(v) “Company PSUs” means awards of performance-based restricted stock units of the Company granted pursuant to any of the Company Stock Plans.

(w) “Company Registered Intellectual Property” means all of the Registered Intellectual Property owned by the Company or any of its Subsidiaries.

(x) “Company RSUs” means awards of restricted stock units of the Company granted pursuant to any of the Company Stock Plans that is not subject to any performance-based vesting conditions.

(y) “Company Stock Plans” means the Instructure Holdings, Inc. 2021 Omnibus Incentive Plan and the Company ESPP.

(z) “Company Stockholders” means the holders of shares of Company Common Stock.

(aa) “Company Termination Fee” means an amount equal to $109,000,000.

(bb) “Confidentiality Agreement” means the agreement listed in Section 9.4 of the Company Disclosure Letter.

A-5

(cc) “Continuing Employee” means each individual who is an employee of the Company or any of its Subsidiaries immediately prior to the Effective Time (including those on vacation, sick leave, maternity leave, military service, lay-off, disability or other paid time off or leave of absence) and continues to be an employee of Parent or one of its Subsidiaries (including the Surviving Corporation) immediately following the Effective Time.

(dd) “Contract” means any binding contract, subcontract, note, bond, mortgage, indenture, lease, license, sublicense or other binding agreement.

(ee) “COVID-19” means the coronavirus (COVID-19) pandemic, including any evolutions, mutations or variants of the coronavirus (COVID-19) disease, and any further epidemics or pandemics arising therefrom.

(ff) “COVID-19 Measures” means any quarantine, “shelter in place”, “stay at home”, workforce reduction, social distancing, shut down, closure, sequester, safety or similar Law, directive, protocol or guideline promulgated by any Governmental Authority, including the Centers for Disease Control and Prevention or the World Health Organization, in each case, in connection with or in response to COVID-19, including the CARES Act and the Families First Coronavirus Response Act, as signed into law by the President of the United States on March 18, 2020.

(gg) “Debt Financing Sources” means, at any time, the entities that have committed to provide or arrange or otherwise entered into agreements in connection with all or any part of the Debt Financing, including any commitment letter relating thereto, and the parties to any joinder agreements, or any definitive documentation entered pursuant thereto or relating thereto, along with their respective Affiliates and their and their respective Affiliates’ former, current and future officers, directors, employees, agents and other Representatives and their respective successors and assigns, in each case, solely in their capacities as such.

(hh) “DOJ” means the United States Department of Justice or any successor thereto.

(ii) “DPA” means Section 721 of the Defense Production Act of 1950.

(jj) “Employee Plan” means each “employee benefit plan” (as defined in Section 3(3) of ERISA), whether or not subject to ERISA, and each other bonus, commission, stock option, stock appreciation right, restricted stock, restricted stock unit, performance stock unit, phantom equity, stock purchase or other equity-based, incentive compensation, profit sharing, savings, retirement, disability, health or welfare insurance, vacation, deferred compensation, employment, individual consulting, severance, separation, termination, retention, change of control, stay bonus, and other similar plan, program, agreement or arrangement (i) that is sponsored, maintained or contributed to, or required to be maintained or contributed to, by the Company or any of its Subsidiaries for the benefit of any current or former employee, director, officer or other individual service provider of the Company or any of its Subsidiaries or (ii) to which the Company or any of its Subsidiaries has any current or contingent liability, other than any such plan, scheme or arrangement that is sponsored, maintained or administered by a Governmental Authority.

(kk) “Environmental Law” means any Law relating to public or worker health or safety, the protection of the environment (including ambient air, surface water, groundwater or land), or pollution.

(ll) “Environmental Permits” means Governmental Authorizations required or issued under Environmental Laws.

(mm) “ERISA” means the Employee Retirement Income Security Act of 1974.

(nn) “ERISA Affiliate” means any person under common control with the Company or any of its Subsidiaries or that, together with the Company, is deemed a “single employer” within the meaning of Section 4001(b)(1) of ERISA or within the meaning of Section 414(b), (c), (m) or (o) of the Code.

A-6

(oo) “Exchange Act” means the Securities Exchange Act of 1934, as amended.

(pp) “Export Control Laws” means, to the extent applicable to the Company or its Subsidiaries, the EC Regulation 428/2009 and the implementing laws and regulations of the EU member states; the U.S. Export Administration Act, U.S. Export Administration Regulations, U.S. Arms Export Control Act, U.S. International Traffic in Arms Regulations, and their respective implementing rules and regulations; the U.K. Export Control Act 2002 (as amended and extended by the Export Control Order 2008) and its implementing rules and regulations; and other similar export control laws or restrictions applicable to the Company and its Subsidiaries and their respective operations from time to time.

(qq) “Financing Sources” means the Debt Financing Sources and the Guarantor and any other Persons, if any, committed to provide the Equity Financing under the Equity Commitment Letter.

(rr) “Foreign Investment Laws” means all applicable Laws relating to foreign investment or that provide for the review of national security or defense matters or the national interest in connection with acquisition of any interest in or assets of a business under the jurisdiction of a Governmental Authority.

(ss) “FTC” means the United States Federal Trade Commission or any successor thereto.

(tt) “GAAP” means generally accepted accounting principles in the United States, consistently applied and as in effect from time to time.

(uu) “Governmental Authority” means any government, political subdivision, governmental, administrative, self-regulatory or regulatory entity or body, department, commission, board, agency or instrumentality, or other legislative, executive or judicial governmental entity, and any court, tribunal, judicial or arbitral body, in each case whether federal, national, state, county, municipal, provincial, local, foreign or multinational.

(vv) “Governmental Authorization” means any authorizations, approvals, licenses, franchises, clearances, permits, certificates, waivers, consents, exemptions, variances, expirations and terminations of any waiting period requirements issued by or obtained from, and any notices, filings, registrations, qualifications, declarations and designations with, a Governmental Authority.

(ww) “Group” has the meaning as used in Section 13(d) of the Exchange Act.

(xx) “Hazardous Substance” means any toxic or hazardous material, substance or waste defined or regulated under Environmental Laws, or any other material, substance or waste for which liability or standards of conduct may be imposed under Environmental Laws due to its hazardous, toxic, deleterious or dangerous properties or characteristics, including petroleum and petroleum products, asbestos, and per- and polyfluoroalkyl substances.

(yy) “HSR Act” means the Hart-Scott-Rodino Antitrust Improvements Act of 1976.

(zz) “Indebtedness” means, with respect to any Person, without duplication, as of the date of determination: (i) all obligations of such Person for borrowed money, (ii) all obligations of such Person evidenced by bonds, debentures, notes or similar instruments, (iii) all letters of credit or performance bonds issued for the account of such Person, to the extent drawn upon, (iv) all lease obligations of such Person capitalized on the books and records of such Person, (v) all Indebtedness of others secured by a lien (other than a Permitted Lien) on property or assets owned or acquired by such Person, whether or not the Indebtedness secured thereby have been assumed and (vi) all guarantees of such Person of any Indebtedness of any other Person other than a wholly owned Subsidiary of such Person.

A-7